Small Molecule Anti-biofilm Agents Developed on the Basis of Mechanistic Understanding of Biofilm Formation
- 1Department of Chemistry, Technical University of Denmark, Lyngby, Denmark
- 2Department of Immunology and Microbiology, Costerton Biofilm Center, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
- 3Singapore Centre for Environmental Life Sciences Engineering, Nanyang Technological University, Singapore, Singapore
Microbial biofilms are the cause of persistent infections associated with various medical implants and distinct body sites such as the urinary tract, lungs, and wounds. Compared with their free living counterparts, bacteria in biofilms display a highly increased resistance to immune system activities and antibiotic treatment. Therefore, biofilm infections are difficult or impossible to treat with our current armory of antibiotics. The challenges associated with biofilm infections have urged researchers to pursue a better understanding of the molecular mechanisms that are involved in the formation and dispersal of biofilms, and this has led to the identification of several steps that could be targeted in order to eradicate these challenging infections. Here we describe mechanisms that are involved in the regulation of biofilm development in Pseudomonas aeruginosa, Escherichia coli, and Acinetobacter baumannii, and provide examples of chemical compounds that have been developed to specifically inhibit these processes. These compounds include (i) pilicides and curlicides which inhibit the initial steps of biofilm formation by E. coli; (ii) compounds that interfere with c-di-GMP signaling in P. aeruginosa and E. coli; and (iii) compounds that inhibit quorum-sensing in P. aeruginosa and A. baumannii. In cases where compound series have a defined molecular target, we focus on elucidating structure activity relationship (SAR) trends within the particular compound series.
During the last two decades it has been realized that the biofilm mode of growth is the predominant life-mode of most bacterial species (Flemming and Wuertz, 2019). In biofilms bacteria are located in densely packed microcolonies concealed in a protective matrix of biopolymers (Tolker-Nielsen, 2015). The ability of bacteria to form biofilms is an ancient trait that during evolution has offered protection from grazing amoebae and antimicrobials. When higher organisms evolved, bacteria adapted to form biofilms at various body sites, and today the extensive use of medical devises in modern health care has provided numerous new niches for bacterial biofilm formation. In the biofilm life-mode the bacteria are tolerant to our present assortment of antibiotics as well as immune system activities (Rybtke et al., 2015; Ciofu and Tolker-Nielsen, 2019). Accordingly, biofilms are the cause of persistent infections associated with various medical implants, and distinct disease states such as urinary tract infection, cystic fibrosis, chronic obstructive pulmonary disease and chronic wounds. The US National Institutes of Health has estimated that more than 80% of all microbial infections in the developed countries involve biofilms.
The problematic infections caused by biofilms have urged researchers to study the molecular mechanisms underlying biofilm formation and biofilm dispersal. This has led to the identification of distinct molecules and mechanisms that could serve as target for novel anti-biofilm drugs. Based on this knowledge, development of several potential anti-biofilm drug candidates is underway. Here we describe our current knowledge of the molecular mechanisms involved in biofilm development for the Gram negative opportunistic pathogens Pseudomonas aeruginosa, Escherichia coli, and Acinetobacter baumannii, which are all causing problematic biofilm infections. Subsequently, we provide examples of chemical compounds that have been developed to inhibit specific biofilm formation processes. These compounds include i) pilicides and curlicides which inhibit the initial steps of biofilm formation by E. coli; ii) compounds that interfere with c-di-GMP signaling in P. aeruginosa and E. coli; and iii) compounds that inhibit quorum sensing in P. aeruginosa and A. baumannii.
Molecular Mechanisms Involved in Biofilm Formation
In this section we review biofilm formation processes of P. aeruginosa, E. coli, and A. baumannii with an emphasis on the molecular mechanisms which are used as targets for the development of anti-biofilm chemicals.
Biofilm formation requires an extracellular matrix that under most conditions is produced by the biofilm forming organism. Compelling evidence suggests that various bacterial species employ so-called c-di-GMP signaling to regulate whether they produce an extracellular matrix and form biofilm, or assume a planktonic lifestyle (Fazli et al., 2014; Jenal et al., 2017). Diguanylate cyclase enzymes (DGCs) catalyze formation of the molecule c-di-GMP, whereas specific phosphodiesterase enzymes (PDEs) catalyze degradation of c-di-GMP in the bacteria. Bacteria typically produce several different DGCs and PDEs, and the available evidence suggests that specificity of c-di-GMP signaling is warranted through physical interactions of specific DGC, PDE, and c-di-GMP effectors (Sarenko et al., 2017). In addition to their catalytic domains these enzymes often contain regulatory domains, and are thought to regulate the life-style (planktonic vs. biofilm) of bacteria in response to environmental cues. An elevated cellular level of c-di-GMP induces the production of biofilm matrix components and drives bacteria to form biofilms, whereas a reduction in the c-di-GMP level down regulates the production of biofilm matrix components and causes dispersal of biofilm bacteria into the planktonic mode of life (Gjermansen et al., 2006, 2010; Christensen et al., 2013). The DGCs and PDEs that make and break c-di-GMP have conserved catalytic GGDEF (Gly-Gly-Asp-Glu-Phe) and EAL (Glu-Ala-Leu)/HD-GYP (His-Asp—Gly-Tyr-Pro) domains, respectively. Genomic analyses have shown that the GGDEF and EAL domains are the most abundant motives among Bacteria. Accordingly, c-di-GMP has been found to be the central biofilm regulator in all Gram negative bacteria investigated to date, and in a number of Gram positive bacteria (Jenal et al., 2017). On the contrary, c-di-GMP is not produced by humans or other mammals.
Quorum sensing (QS) is another regulatory process that plays a role in biofilm formation of a variety of bacterial species, and also functions as an overall regulator of the expression of virulence factors (Juhas et al., 2005). QS is a bacterial cell-to-cell communication process that relies on the production, sensing and response to extracellular signaling molecules. QS allows groups of bacteria to synchronously alter the expression of specific genes, mainly in response to changes in their population density. In Gram negative bacteria the majority of QS systems employ acyl homoserine lactone (AHL) signal molecules. The systems function by means of one or more AHL synthases that produce AHL molecules which can pass the bacterial membranes and upon reaching a threshold concentration binds to and activates one or more transcriptional activators which in turn activate transcription of specific target genes. The concentrations of signal molecules correlate to the density of the bacterial population, enabling density dependent control of gene expression.
P. aeruginosa biofilms are causing a number of persistent infections, including cystic fibrosis pneumonia, chronic obstructive pulmonary disease related infections, chronic wound infections, chronic otitis media, chronic bacterial prostatitis, and medical device-related infections especially associated with urinary tract catheters and endotracheal tubes (Tolker-Nielsen, 2014).
Biofilm formation by P. aeruginosa can initiate through the adhesive action of several components, including flagella (O'Toole and Kolter, 1998), type IV pili (O'Toole and Kolter, 1998; Deziel et al., 2001; Chiang and Burrows, 2003), Cup fimbria (Vallet et al., 2001), extracellular DNA (Whitchurch et al., 2002), and Psl polysaccharide (Ma et al., 2006). Many of these components are also important constituents of the extracellular matrix at later stages of biofilm formation. The exopolysaccharide Psl is cell-surface associated and functions as an adhesin in the initial phase of biofilm formation, but relocates as a peripheral exopolysaccharide at later stages of biofilm formation (Ma et al., 2009). The surface adhesin CdrA binds to Psl, and it is required for Psl-mediated aggregation of P. aeruginosa cells (Borlee et al., 2010). Pel is a cationic exopolysaccharide produced by P aeruginosa, and it has been shown to cross-link extracellular DNA in the biofilm matrix (Jennings et al., 2015). Overproduction of alginate exopolysaccharide enables mucoid P. aeruginosa strains to form biofilm persistent infections in the lungs of cystic fibrosis patients (Hoiby, 1977). Moreover, P. aeruginosa rugose small colony variants that overproduce Psl and Pel exopolysaccharide show enhanced persistence in cystic fibrosis lungs (Starkey et al., 2009). In addition, the lectins LecA/LecB and the functional amyloid protein Fap can play a role as matrix components in P. aeruginosa biofilms (Tielker et al., 2005; Diggle et al., 2006b; Dueholm et al., 2013).
Synthesis in P. aeruginosa of the biofilm matrix components Psl, Pel, alginate, CdrA, type IV pili, and Cup fimbriae is positively regulated by c-di-GMP (Fazli et al., 2014). Conversely, c-di-GMP is a negative regulator of motility of P. aeruginosa (Simm et al., 2004). The c-di-GMP content in P. aeruginosa is adjusted via the activity of 17 proteins with a GGDEF domain, 9 proteins with an EAL/HD-GYP domain, and 16 proteins with both a GGDEF and an EAL domain. Christensen et al. (2013) constructed a recombinant bacterial P. aeruginosa strain, where the cellular level of c-di-GMP can be reduced by addition of an inducer that activates transcription of a PDE gene, and demonstrated that in vitro P. aeruginosa biofilms disperse in response to a reduction in the cellular c-di-GMP content (Christensen et al., 2013). In addition, evidence was provided that murine implant-associated P. aeruginosa biofilm infections can be cured through a reduction of the bacterial c-di-GMP content (Christensen et al., 2013).
QS in P. aeruginosa is mediated through the LasI/LasR and RhlI/RhlR proteins that produces and senses the signal molecules 3-oxo-C12-homoserine lactone (HSL) and C4-homoserine lactone (C4-HSL) (Schuster and Greenberg, 2006). Moreover, P. aeruginosa employs a Pqs system that produces and senses 2-heptyl-3-hydroxy-4-quinolone (termed PQS) (Diggle et al., 2006a). The systems are hierarchically arranged with LasR regulating the Rhl and Pqs systems (Diggle et al., 2006a). QS regulates the production of a number of compounds that play a role in the formation and persistence of P. aeruginosa biofilms. Among these QS-regulated factors is extracellular DNA that contributes to the stability of P. aeruginosa biofilms and plays a role in the antimicrobial tolerance displayed by the biofilms (Allesen-Holm et al., 2006; Chiang et al., 2013). Moreover, the production of rhamnolipid is QS regulated, and this amphipathic molecule plays a role in biofilm development and resistance of P. aeruginosa biofilms to phagocytizing immune cells (Pamp and Tolker-Nielsen, 2007; Alhede et al., 2009). Thus, inhibition of QS decreases the antibiotic tolerance of P. aeruginosa biofilms and reduces resistance to host immune responses (Jakobsen et al., 2017a).
E. coli is the primary infectious agent in urinary tract infections, including cystitis (infection of the bladder or lower part of the urinary tract) and pyelonephritis (infection of the kidneys or infections associated with the upper urinary tract). The bacterium is able to form biofilms on catheter material, on the bladder wall, and within bladder epithelial cells, and biofilm formation is often related to infection relapses (Anderson et al., 2003; Justice et al., 2004; Soto et al., 2006; Rosen et al., 2007, 2008).
Biofilm formation by E. coli can be governed by a number of different adhesins and extracellular matrix components. Flagella may play a role in transport of the bacteria to a surface, and in adhesion to the surface (Pratt and Kolter, 1998). The proteinaceous curli fibers are a major component of the E. coli biofilm matrix, and they are required in the initial stages of E. coli attachment to proteins on the host cells (Olsen et al., 1989; Ben Nasr et al., 1996; Prigent-Combaret et al., 2000; Chapman et al., 2002; Serra et al., 2013). Curli fibers are comprised of the two proteins, CsgA and CsgB, where CsgB primes the polymerization of CsgA (Hammar et al., 1995). Type 1 and P pili are adhesive surface structures which are important in E. coli infections (Pratt and Kolter, 1998; Schembri and Klemm, 2001; Niba et al., 2007). Type 1 pili are central for the irreversible attachment of the cells to a surface, and type 1 pili deficient strains shows significant impairment in biofilm formation (Pratt and Kolter, 1998; Niba et al., 2007). Using a mouse model, it has been shown that uropathogenic E. coli (UPEC) strains, that expresses type 1 pili, have a survival advantage in the bladder (Mulvey et al., 1998), and that E. coli lacking type 1 or P pili is greatly attenuated in causing urinary tract infections (Sivick and Mobley, 2010). Type 1 pili contain repeating FimA subunits which assemble to a coli-rod structure that is tipped with FimH adhesin molecules (Brinton, 1965; Barnhart et al., 2003; Korea et al., 2011). Absence of FimH reduces adhesion both in vitro and in the bladders of mice (Langermann et al., 1997; Mulvey et al., 1998). FimH is responsible for a specific adhesion to mannose residues on epithelial cells, thereby facilitating infection (Pratt and Kolter, 1998; Hertig and Vogel, 2012; Rakshit and Sivasankar, 2014). P pili contain PapA subunits assembled to a helical structure, which at the tip anchors the adhesin PapG (Gong and Makowski, 1992; Bullitt and Makowski, 1995). PapG enables E. coli cells to bind to epithelial kidney cells in the host (Busch et al., 2015). Antigen43 is an autotransporter protein, which has been linked with higher intracellular persistence in urinary tract infections (Anderson et al., 2003; Klemm and Schembri, 2004; Van Der Woude and Henderson, 2008; Luthje and Brauner, 2010). In addition to the protein components, the exopolysaccharides cellulose, poly-GlcNAc (PGA), and colanic acid are important structural components of the matrix of E. coli biofilms (Danese et al., 2000; Wang et al., 2004; Serra et al., 2013; Subashchandrabose et al., 2013; Besharova et al., 2016). Moreover, extracellular DNA can function as an important matrix component in E. coli biofilms (Devaraj et al., 2015).
Synthesis in E. coli of the biofilm matrix components cellulose, PGA and curli fimbria is positively regulated by c-di-GMP (Brown et al., 2001; Brombacher et al., 2003, 2006; Weber et al., 2006; Jonas et al., 2008; Pesavento et al., 2008; Boehm et al., 2009). Conversely, c-di-GMP is a negative regulator of motility of E. coli (Simm et al., 2004). The c-di-GMP content in E. coli is determined by the activity of several GGDEF/EAL/HD-GYP domain proteins; e.g., the lab strain E. coli K12 possess 12 DGCs and 13 PDEs (Hengge et al., 2016; Povolotsky and Hengge, 2016). Evidence has been provided that there is a hierarchical arrangement of DGCs and PDEs, with a few master controllers (Sarenko et al., 2017). The PDE, PdeH (formerly YhjH) was shown to eradicate global effects of several DGCs, thereby limiting them to act on local systems. The major DGC was found to be DgcE, which is a primary controller of the c-di-GMP level in E. coli (Sarenko et al., 2017).
E. coli does not encode an AHL based QS system. However, it evidently employs a furanosyl borate diester (AI-2) based QS system, and evidence has been presented that this system is involved in regulation of the synthesis of some of the biofilm matrix components (Beloin et al., 2008).
The most common infections caused by A. baumannii are pneumonia, meningitis, urinary tract infection, skin and soft tissue infection, wound infections and bacteremia (Visca et al., 2011). The increased use of mechanical ventilation and central venous and urinary catherization has greatly increased the incidence of A. baumanni infections (Wong et al., 2017). The ability of A. baumanni to form biofilm is contributing significantly to the recalcitrance of these infections to antibiotic treatment.
The mechanisms involved in biofilm formation for A. baumanni are less studied than for P. aeruginosa and E. coli. However, a number of adhesins and extracellular components have been identified as playing a role in biofilm formation of A. baumanni. The bacteria lack flagella, but surface adhesion is facilitated by Csu pili and the OmpA outer membrane protein (Dorsey et al., 2002; Tomaras et al., 2003; Gaddy et al., 2009). Besides adhesion to abiotic surfaces, OmpA binds to epithelial cells and thus mediate biofilm formation on biotic surfaces (Gaddy et al., 2009). In addition, a biofilm associated protein (Bap) has been reported to play a role in A. baumanni biofilm formation (Loehfelm et al., 2008). Evidence was provided that Bap is important in cell-cell adhesion and in keeping the structure of mature biofilms (Loehfelm et al., 2008). Moreover, A. baumanni can synthesize the exopolysaccharides alginate and poly-β-1,6-N-acetylglucosamine (PNAG) which can function as important constituents of the biofilm matrix (Lee et al., 2008; Choi et al., 2009). Extracellular DNA is also a matrix component in A. baumannii biofilms (Sahu et al., 2012).
There is a lack of knowledge regarding a role of c-di-GMP signaling in the regulation of biofilm formation by A. baumannii. However, a study employing an in silico pharmacophore-based screen to identify small-molecule inhibitors of DGC enzymes, found that the hit compounds could inhibit biofilm formation of A. baumannii (Sambanthamoorthy et al., 2014). Synthesis of Csu pili is known to be regulated by the BfmSR two-component system in A. baumannii (Tomaras et al., 2008; Liou et al., 2014).
QS has been shown to play a role in regulation of biofilm formation by Acinetobacter species (Anbazhagan et al., 2012). A. baumannii possess an AHL-based QS system with AbaI functioning as the AHL synthase and AbaR functioning as the AHL receptor. An abaI mutant, not able to produce AHL, was shown to have defects in the later stages of biofilm formation (Niu et al., 2008). In addition, it was shown that addition of AHL to A. baumannii cells resulted in an increased expression of Csu pili, and a stimulation of biofilm formation (Luo et al., 2015). Moreover, a low concentration of Fe3+ was found to induce AHL-based QS in A. baumannii, and to promote the formation of robust biofilms (Modarresi et al., 2015). A. baumannii is capable of producing a quorum quenching enzyme designated AidA, and Lopes at al. found that activation of AidA in A. baumannii resulted in inhibition of biofilm formation (Lopez et al., 2017).
Compounds That Interfere With Biofilm Formation
In this section we describe pilicides and curlicides which inhibit the initial steps of biofilm formation by E. coli, and compounds that interfere with c-di-GMP signaling in P. aeruginosa and E. coli, as well as compounds that inhibit QS in P. aeruginosa and A. baumannii. A direct comparison of compound efficiencies is difficult due to the lack of standardization between assays used in the different studies. Even in studies investigating modulation of the same protein, there is often a variation in the used bacterial strains, growth media and assay. This makes a quantitative comparison of activities (e.g., IC50 values) from various studies problematic and in some cases even misleading. Therefore, this review is focused on reviewing activity trends observed within each assay as well as giving a more qualitative comparison of structures and relative biological effects across different studies.
Compounds That Modulate the Function of Pili and Curli in Escherichia coli
Bacterial attachment is an essential step in most bacterial infections, and failure to attach leads to eradication of the pathogenic organism. Accordingly, bacteria have evolved sophisticated pili and fimbriae systems for epithelial surface attachment (Mulvey, 2002; Fronzes et al., 2008; Cusumano and Hultgren, 2009), hereby facilitating invasion and colonization of the underlying tissue. Type 1 and p pili are two of such pili systems involved in attachment and invasion of UPEC strains in the host, leading to urinary tract infections. Specifically, Type 1 pili have been implicated in infections of the lower urinary tract, which results in cystitis (infection of the bladder), while p pili are associated with pyelonephritis (infection of the kidney). The p pili and type 1 pili are both consisting of a pilus rod connected to a flexible end tip (fibrillum) that enable interactions with the target.
Pili are often assembled via a highly conserved mechanism called the chaperone–usher pathway (CUP) utilized by numerous adhesive organelles in Gram negative bacteria, including E. coli and P. aeruginosa (Figure 1) (Jacob-Dubuisson et al., 1994; Nuccio and Baumler, 2007). The construction of pili by the CUP proceeds from the top to bottom, meaning that the first subunit to be introduced is the adhesin (PapG or FimH), which is followed by introduction of the rest of the tip fibrillum and adaptor subunits (PapF, E, and K or FimG and F), the pilus base (PapA or FimA) and lastly, in the case of the Pap system, the termination and anchor subunit (PapH) (Busch et al., 2015). The CUP pili construction system contains several feasible targets for the development of compounds that block this assembly and thus pili formation.
Figure 1. Schematic representation of the P pili. The chaperones attached to the last subunit to be incorporated into each pilus are shown in yellow triangle. P pili are terminated at the outer membrane by the termination subunit, PapH. No such subunit is known in the Fim system. The pilicide bound to the chaperone-pilus subunit complex inhibit interaction with usher for further docking.
Among this kind of compounds are mannocides that compete for binding in the mannose binding pocket present in the FimH pilus lectin of type I pili, blocking its binding with their mannose rich receptors in eukaryotic cells. To date, compounds like biphenylmannosides have proved effective in vitro to prevent biofilm formation of the UPEC and also to disrupt preformed biofilm (Han et al., 2010). Their oral administration was effective in clearing chronic urinary tract infections in mice and in potentiating the activity of the antibiotic trimethoprim sulfamethoxazole (Cusumano et al., 2011). Bacterial pilus assembly requires the presence of periplasmic chaperones. Thus, development of compounds that bind to chaperones have been of high interest. By inhibiting pilus assembly, such compounds would interfere with bacterial attachment to the host, and therefore they constitute potential novel antibiofilm agents. This type of compounds is referred to as pilicides (Aberg and Almqvist, 2007).
P pili are assembled by the chaperone PapD that binds to and caps interactive surfaces on each pilus subunit thus preventing premature aggregation during their secretion into the periplasmic space. The high degree of structural homology and conserved mechanism of action between the CUP proteins in various pathogens (Rose et al., 2008), make compounds that target this system attractive as potential broad-spectrum anti-virulence compounds.
C-Terminal peptides of both PapG (1, Figure 2) and PapH have been shown to bind to the chaperone, leading to effective inhibition of further binding of pilus subunits (Karlsson et al., 1998). This has provided efficient probe molecules useful for studying the intricate processes in the CUPs. However, the use of peptides as drugs has several drawbacks, including poor absorption after oral administration, rapid degradation and/or excretion. Therefore, focus has been given to development of small-molecule peptidomimetics as potential anti-virulence compounds.
Figure 2. The two final amino acids (Phe313-Pro314) in the C-terminal of PapG bound to PapD served as template for design of the pilicide scaffold that inhibit pilus assembly.
The high amount of information available regarding PapG C-terminus interactions with the chaperone (Svensson et al., 2001; Emtenäs et al., 2003a) has been used for a structure-based design of small-molecule structures that mimick the PapG C-terminal. The dihydrothiazolo ring-fused 2-pyridone scaffold (2, Figure 2) is the most widely studied pilicide structures, targeting the Arg8/Lys112 cleft region of the chaperone. This scaffold has the terminal carboxylic acid moiety, important for interaction with the Arg8 and Lys112 residues in the chaperone cleft (Figure 2). Furthermore, the scaffold can be further decorated by the installation of substituents at various positions to introduce important hydrophobic motifs (e.g., Leu311 residue) and/or exploit other potentially useful interactions.
The importance of the bicyclic 2-pyridone system was clearly indicated, as the monocyclic 2-pyridone (3, Figure 2) showed a considerable lower biological activity as compared to the corresponding bicyclic compound (Pemberton et al., 2008).
The first generation bicyclic 2-pyridone pilicides (4, 5, Figure 3) (Svensson et al., 2001; Lee, 2003), suffered from poor water solubility, which limited their utility. However, introducing an aminomethylene substituent in the open C6 position in the 2-pyridone scaffold (R3, Figure 2) solved this problem, resulting in 2-pyridone (6, Figure 3) binding chaperones in the low millimolar range (Figure 3) (Hedenstrom et al., 2005).
Figure 3. (A) First generation pilicides, compound 4 and 5 (Svensson et al., 2001; Lee, 2003) suffered from low solubility. Aminomethylene substitution of pilicide 5 resulted in compound 6 with improved solubility properties (Hedenstrom et al., 2005). (B) Pilicides containing carboxylic acid isosteres, including tetrazoles (8), acyl sulfonamides (9) and hydroxamic acids (10) are tolerated (Åberg et al., 2008). (C) SAR study to investigate substitution of position C-2 in the pilicide scaffold, including both saturated (12) and unsaturated (13) analogs (Chorell et al., 2010). (D) Small modifications in the phenyl ring allowed identification of ring-fused 2-pyridones that exhibit dual pilicide-curlicide activity (Cegelski et al., 2009).
The carboxylic acid group on the pilicide scaffold is vital for the activity of the pilicides, and exchanging the carboxylic acid for other functionalities, including -CO2Me, -CH2OH, -CH2OMe, -CHO, or -CH3 substantially reduced the pilicide activity (Aberg et al., 2005a). However, carboxylic acid isosteres comprising tetrazoles (8, Figure 3), acyl sulfonamides (9, Figure 3) and hydroxamic acids (10, Figure 3) are tolerated and can in some cases lead to improved pilicide's potency (Åberg et al., 2008).
The carboxylic acid functionality was originally designed to interact with Arg8 and Lys112 in the chaperone cleft (Figure 2). However, a later NMR-based study elucidating the pilicides' binding site revealed that the cleft of the chaperone is not the only possible binding site (Hedenstrom et al., 2005). Instead, the study suggested that pilicides affect E. coli pilus formation either by binding in the chaperone cleft, or by affecting the orientation of the flexible F1–G1 loop of the chaperone, both of which are part of the surface that is involved in interactions with pilus subunits. This latter binding site was later verified by X-ray crystallography of a pilicide-PapD complex (Pinkner et al., 2006).
The effect of varying the C-7 and C-8 (Emtenas et al., 2002; Aberg et al., 2005b; Aberg and Almqvist, 2007; Cegelski et al., 2009; Chorell et al., 2012) position of the 2-pyridone scaffold (Figure 2) have been intensively examined, based on two main objectives. First, to improve the peptide mimicking properties of the identified hits, and secondly to establish structure–activity relationships (SARs) regarding pilicide activity. In general, the nature of the substituent at both the C-7 and C-8 position was found to strongly affect the biological response (Emtenas et al., 2002; Chorell et al., 2012).
In 2011, Chorell et al. conducted a detailed SAR study of the effect of C7 substitution (Chorell et al., 2011). Based on their studies, Almqvist et al. delineated two broad activity trends: (1) Hydrophobic, sterically demanding C-7 substituents are beneficial. (2) Extended ether linkers are allowed and can in some cases improve activity whereas linkers incorporating basic amines, amides and sulphonamides, as well as heteroaryls diminish biofilm inhibition capacity. Overall, the most promising C-7 substituents were found to be 1-naphthylmethyl, naphthoxymethyl, 3-tolylethyl, and 2,3-dimethylphenoxymethyl groups.
Similarly, large and hydrophobic aromatic substituents are important in the R1 position of the 2-pyridinone to get good binding to the chaperone. Compounds containing a phenyl, indole, thiophene or 3,4-methylenedioxyphenyl group at C-8 were effective, while incorporation of pyridine and the smaller methoxy, cyclopropyl, and isopropyl substituents resulted in compounds with reduced potency (Chorell et al., 2012). Furthermore, the R1 substituent has been shown to have an impact on the C2-position in the 2-pyridone (Emtenäs et al., 2003b). For example, 2-pyridone with cyclopropyl at the R1 position was more prone to racemization than 2-pyridone with phenyl at the R1 position.
In 2010 Chorell et al. published a study investigating substitution of the C-2 position in the pilicide scaffold, including both saturated and unsaturated analogs (12, 13, Figure 3) (Chorell et al., 2010). As a result of their analysis, Almqvist and co-workers could draw some general conclusions regarding the structural features of the C-2 position in dihydrothiazolo ring-fused 2-pyridone molecules that are necessary for blocking pilus formation. Their results disclosed that the addition of substituents in the C-2 position of the pilicide scaffold significantly enhanced the potency of the pilicides, leading to increased inhibition of pili dependent biofilm formation. However, the effect of the spatial arrangement on activity was different between the analogs. For example, with phenyl substitution in the C-2 position, the unsaturated analog had higher potency than the saturated counterpart, whereas with methyl in the C-2 position, the situation was the opposite; the saturated analog had higher potency than the unsaturated.
On the basis of the results with the unsaturated phenyl analog, a more comprehensive SAR study with unsaturated C-2 aryl and heteroaryl substituents (13, Figure 3) was performed. Many of the compounds containing aryl and heteroaryl-substituents efficiently inhibited the formation of pili dependent biofilm. Especially, the benzyl substituted compound 14 (Figure 3) showed promising properties with an estimated EC50 of 7 μM. Interestingly, compounds containing more sterically demanding substituents, including indole and bensodioxane were not tolerated and resulted in no activity.
Almqvist et al. also investigated the importance of the heteroatom in the fused 2-pyridone scaffold, drawing attention to imidazolines and oxazolines. While exchanging the sulfur for a secondary amine resulted in a distinct drop in activity, activities of the oxazolo fused 2-pyridones were comparable to the parent sulfur containing pilicides (Pemberton et al., 2008).
Besides the pili described in the preceding section, E. coli and other Enterobacteriaceae produce and display adhesive amyloid fibers termed curli at the bacterial cell surface (Olsen et al., 1989; Kikuchi et al., 2005). Curli are critical for biofilm development in E. coli, making this extracellular macromolecule a highly relevant anti-biofilm target. Assembly of curli depends upon at least six proteins known as CsgA, CsgB, CsgD, CsgE, CsgF, and CsgG. CsgA and CsgB are the major and minor curli subunits, respectively, while CsgE, CsgF, and CsgG are accessory proteins that direct the extracellular localization and facilitate assembly of curli subunits into fibers.
Curlicides designate compounds that inhibit uropathogenic E. coli curli biogenesis and prevent the polymerization of CsgA; being important for anchoring the curli amyloid fiber to the bacterial outer membrane (Hammar et al., 1996). Thiazolo ring-fused 2-pyridones are peptidomimetics that target important protein-protein interactions in macromolecular assembly (Svensson et al., 2001; Emtenäs et al., 2003a), which, as discussed above, provides an excellent scaffold for development of pilicides (for example 11, Figure 3). However, their ability to disrupt protein-protein interactions has also been investigated to identify scaffolds that show inhibitory effects on curli biogenesis (Aberg et al., 2005b). While the cyclopropyl-substituted pyridone 11 (Figure 3) with strong pilicide activity, exerted no anti-curli activity (Cegelski et al., 2009), exchange of the cyclopropyl group of 11 with larger aryl substituents generated compound 15 and 16 (Figure 3) that gained curlicide activity and blocked curli-dependent biofilms. Interestingly, 15 and 16 both retained their ability to prevent pili formation, thus exhibiting dual pilicide-curlicide activity (Cegelski et al., 2009). Compounds that can act as both pilicides and curlicides could have increased therapeutic value as they could inhibit the formation of several adhesion fibers that are important in biofilm formation (Cegelski et al., 2009).
Modulators of c-di-GMP Signaling in Pseudomonas aeruginosa and Escherichia coli
Cyclic di-GMP has emerged as an almost universal positive regulator of biofilm formation in Gram negative bacteria (Figure 4) (Jenal et al., 2017). There are two basic concepts for external intervention that reduces the c-di-GMP level in bacteria: decreasing c-di-GMP formation by inhibition of DGCs or increasing c-di-GMP degradation by activation of PDEs.
DGCs contain GGDEF catalytic domains and function as homodimers. The GGDEF domains are placed at the interface of the dimer and are important for the binding of two molecules of GTP as well as their conversion into c-di-GMP with Mg2+ functioning as cofactor (Valentini and Filloux, 2016). Some DGC proteins, such as PelD from C. crescentus, WspR from P. aeruginosa, and YdaM from E. coli as well as DgcK and DgcL from Vibro cholera, possess an inhibitory site (I-site), placed only five amino acids away from the active site (Valentini and Filloux, 2016). A characteristic motif of the I-site is an RxxD sequence (x is any amino acid), where the c-di-GMP product can bind to, thereby allostericcally inhibiting its own synthesis (Chan et al., 2004; Kalia et al., 2013).
So far, two main types of c-di-GMP PDEs have been characterized, containing either the EAL or HD-GYP domain (Schirmer and Jenal, 2009; Romling et al., 2013). The primary role of EAL domain PDEs is to linearize c-di-GMP into 5′-phosphoguanylyl-guanosine (5′-pGpG) and only slowly hydrolyze 5′-pGpG to GMP. EAL-domain-containing proteins require Mg2+ or Mn2+ ions for catalysis, while inhibited by Ca2+ (Schmidt et al., 2005). The HD-GYP domain-containing PDEs are the second group of c-di-GMP specific PDEs, functioning by hydrolyzing c-di-GMP directly into two GMP molecules. Like the EAL domain proteins, the HD-GYP domain proteins have a binuclear Fe2+ or Mn2+ center (Romling et al., 2013).
Due to the highly conserved nature of c-di-GMP signaling systems in bacteria, and the strong evidence for their role in regulating biofilm formation, targeting c-di-GMP signaling systems is a promising approach for development of broad-spectrum small molecules for treatment of biofilm-associated infections.
Both PDEs and DGCs interact extensively with c-di-GMP, making it challenging to design c-di-GMP analogs that selectively target PDEs and not DGCs, and vice versa. In addition, most bacteria synthesize multiple DGCs and PDEs, each of which affect distinct phenotypes (Opoku-Temeng and Sintim, 2017). For example, Lory et al. observed that P. aeruginosa overexpressing the DGC PA2870, and other GGDEF domain proteins such as SiaD and PA0575, showed no change in ability to form biofilm, while P. aeruginosa overexpressing the DGCs WspR, RoeA, and PA3702 showed increased biofilm formation (Kulasakara et al., 2006). Just like DGCs, not all PDEs affect the global concentrations of c-di-GMP but regulate other processes, e.g., the synthesis of virulence factors (Opoku-Temeng and Sintim, 2017) Therefore, targeting inhibition of some of these virulence-associated PDEs (as long as they do not regulate biofilm dispersal) with small molecules could be pursued for blockage of virulence. However, the complexity of the c-di-GMP signaling pathway is challenging when developing small molecule modulators. Nonetheless, some progress has been made and several inhibitors of c-di-GMP metabolizing enzymes that affect biofilm formation and motility have been described. Here we discuss various reported inhibitors of c-di-GMP signaling.
Small Molecule Inhibitors
The history of small molecule DGC-inhibitors started in 2006 with work by Webb and colleagues, who discovered that the molecule nitric oxide (NO) can induce dispersal of P. aeruginosa biofilms (Barraud et al., 2006). The authors suggested a combined treatment approach with a NO donor and an antimicrobial agent to eradicate biofilm infections. They examined various NO donors, specifically sodium nitroprusside (SNP) 17, S-nitroso-L-glutathione (GSNO) 18 and S-nitroso-N-acetylpenicillamine (SNAP) 19 (Figure 5) in combination with the antimicrobial agents tobramycin, hydrogen peroxide, and sodium dodecyl sulfate. Of the investigated NO donors, SNP was shown to be the most potent inhibitor of biofilm formation in P. aeruginosa (Barraud et al., 2006).
Figure 5. (A) NO donors exerting biofilm-inhibitory effect (Barraud et al., 2006). (B) Sulfathiazole 20 and azathioprine 21; small molecules found to interfere with c-di-GMP biosynthesis by the group of Antoniani et al. (2010, 2013). (C) Compound identified as DGC inhibitor (DI) by Sambanthamoorthy et al. (2014). (D) Inhibitors of DGC discovered by Sambanthamoorthy et al. (2014).
Although NO-donors were shown to exert biofilm inhibitory effects, it was not until 2009 that the biochemical understanding of this effect was revealed (Barraud et al., 2009). Kjelleberg et al. showed that low nontoxic levels of NO stimulated PDE activity in P. aeruginosa, causing an overall decrease in intracellular c-di-GMP, leading to biofilm-dispersal. Besides the reduction of the intracellular c-di-GMP level, NO-donors cause a downregulation of the synthesis of pyoverdine (Kang et al., 2017), which is a siderophore responsible for recruitment of essential iron for biofilm formation (Kang and Kirienko, 2017).
In 2010, Antoniani et al. developed an assay for high throughput screening of DGC-inhibitors. They screened a library of 1120 compounds, which allowed them to identify the antimicrobial sulfathiazole 20 (Figure 5), as an efficient inhibitor of the E. coli DGC-protein AdrA (Antoniani et al., 2010). Sulfathiazole consists of a free aniline, an aromatic sulfonamide and a thiazole ring, all polar and rather electron rich components. This results in a molecular structure with two planar sides that is bended around the sulfonamide moiety (Figure 5). Subsequently, Landini et al. provided evidence that azathioprine 21 (Figure 5), an anti-inflammatory drug used in treatment of several autoimmune conditions, can impede c-di-GMP biosynthesis in E. coli (Antoniani et al., 2013).
Comparing azathioprine 21 to sulfathiazole 20 (Figure 5), they share structural similarities with to (hetero) aromatic parts bended around a polar moiety (sulfide and sulfonamide, respectively). Sulfathiazole 20 and azathioprine 21 (Figure 5) do not interfere with the c-di-GMP biosynthesis through inhibition of DGC activity. Instead, sulfathiazole 20 and azathioprine 21 was shown to affect nucleotide metabolism, leading to an alteration of nucleotide pools, hereby affecting c-di-GMP substrate availability.
In 2012, Sambanthamoorthy et al. published the screening of approx. 66.000 compounds for inhibition of DGC activity in Vibrio cholerae (Sambanthamoorthy et al., 2012). After several rounds of screening and optimization, 8 compounds were identified with good antagonistic effect toward multiple DGC enzymes, with N-(4-anilinophenyl)benzamide 22 (Figure 5) showing significant reduction of biofilm formation also in P. aeruginosa.
In 2014, Palys et al. reported an in silico pharmacophore-based screening of ~15.000 small molecules for their ability to inhibit DGC and control biofilm development (Sambanthamoorthy et al., 2014). Four compounds, LP 3134 23, LP 3145 24, LP 4010 25, and LP 1062 26 (Figure 5), were identified that significantly reduced WspR activity in P. aeruginosa. Further studies revealed that the compounds significantly prevented biofilm formation by P. aeruginosa and A. baumannii in a continuous-flow system (Sambanthamoorthy et al., 2014). All four molecules were found to disperse biofilm in P. aeruginosa and inhibited biofilm development on urinary catheters, whereas only one of the molecules (23) dispersed A. baumannii biofilms.
A virtual screening approach was also undertaken by Rinaldo and coworkers, who reported the in silico screening of ~2.3·107 compounds from the ZINC database, with the aim to identify potent DGC inhibitors targeting the active site (Fernicola et al., 2016). The active site of the DGC PleD from C. crescentus was used as structural template. Seven of the tested compounds showed significant reduction in PleD DGC activity, with Amb2250085 27a and Amb379455 27b (Figure 6) both containing the sulfonohydrazide, the nitro-group and the catechol moiety, being the most efficient PleD inhibitors. Further studies revealed that 27a was very sensitive to metals, such as Mg2+, which completely abolished the inhibitory activity of both PleD, WspR and YfiN. However, 27b proved not to be interfered by the presence of the divalent metal ion. 27b showed strong inhibition of DGCs, including WspR and YfiN from P. aeruginosa, through binding to the active site of the DGCs.
Figure 6. (A) DGC inhibitors investigated by Rinaldo et al., all significantly reduced PleD activity. Amb379455 27b being the most promising (Fernicola et al., 2016). (B) Structual comparison of LP3134 23 and Amb379455 27b. (C) The small molecule ebselen (Eb) 28a identified as an DGC inhibitor by Lee and coworkers, and its oxidized form ebselen oxide (EbO) 28b (Lieberman et al., 2014). (D) 29a discovered by the Sintim group, and further investigated the importance of the benzoisothiazolinone moiety by testing 29b and 29c (Zheng et al., 2016). (E) H19 30a and 925 30b; two Alg44 (pilZ domain) inhibitors identified by Wang et al., and structural features further investigated by (Zhou et al., 2017). (F) The small molecules terrein 31 and 32 used by Kim et al. in studying the correlation between regulation of c-di-GMP levels and QS.
It is relevant to notice the structural similarity when comparing Amb379455 27b and the previously mentioned LP 3134 23, as illustrated in Figure 6. Both DGC inhibitors share the N-benzylidenebenzohydrazide moiety that is predicted to interact with an amino group in the active site (the Asn335 residue). Furthermore, they both contain the pyrogallol unit, a moiety with high polarity and strong coordination properties. Polyphenols characteristically possess a significant binding affinity for proteins (Papadopoulou and Frazier, 2004). Furthermore, pyrogallol can undergo reversible oxidation, to generate reactive oxygen species (ROS), resulting in DNA damage (Beaber et al., 2004; Kohanski et al., 2007). Worth mentioning, evidence suggests that polyphenolic compounds can interfere with bacterial QS by blocking AHL-mediated signaling between bacteria (Huber et al., 2003).
In 2014, Lieberman et al. identified the small molecule, ebselen (Eb) 28a (Figure 6), as an inhibitor of allosteric binding of c-di-GMP to receptors containing an RxxD domain, including WspR and PelD of P. aeruginosa (Lieberman et al., 2014). It was found that Eb 28a covalently modified DGCs by forming a bond between the selenium in Eb 28a and a thiol in a cysteine residue in the allosteric inhibitory site. It was further demonstrated that the allosteric inhibition of DGCs also inhibited the activity of the DGCs. The oxidation state of selenium was important for activity, as the corresponding ebselen oxide (EbO) 28b (Figure 6) showed reduced inhibition.
In 2016, Sintim et al., screened 250.000 compounds in order to find a small molecule PDE inhibitor that bind to the EAL domain of YahA in E. coli (Zheng et al., 2016). A handful of such PDE binders were identified and tested for their inhibitory effect of RocR (from P. aeruginosa) with only the benzoisothiazolinone derivative 29a (Figure 6) successfully inhibiting the hydrolysis of c-di-GMP. 29a was tested against a series of PDEs from different bacteria and shown to be highly selective toward inhibition of RocR. The importance of the benzoisothiazolinone moiety was clearly indicated as 29b and 29c (Figure 6) showed a dramatic decrease in inhibitory effect. RocR is an example of a virulence-associated PDE that does not affect the global c-di-GMP level in P. aeruginosa and therefore, inhibition of RocR may hold potential for inhibiting virulence. 29a was the first example of cell-permeable PDE inhibitors that selectively inhibits one type of PDE without affecting other PDEs. The tested PDEs were YahA (E. coli), DipA (P. aeruginosa), PvrR (P. aeruginosa), PA4108 (P. aeruginosa), and RocR (P. aeruginosa). Furthermore, they showed no effect on the DGCs WspR and D70E from P. aeruginosa.
In 2017, Wang et al. identified two compounds, H19 30a and 925 30b (Figure 6) that interrupted c-di-GMP binding to Alg44 (PilZ domain) in P. aeruginosa, thereby inhibiting its ability to produce alginate, an exopolysaccharide polymer which is part of the biofilm matrix (Zhou et al., 2017). The sulfhydryl group, forming a covalent disulfide bond with Cys-98 in Alg44 (Figure 6), was found to be of high importance for activity. Furthermore, a broad range of alkyl substituents was tested without any improvement of inhibitory activity (Zhou et al., 2017).
In 2018, Kim et al. published a study that suggested a connection between c-di-GMP signaling and QS in P. aeruginosa (Kim et al., 2018). Terrein 31 (Figure 6) was found to inhibit biofilm formation by blocking QS receptors, similar to the effect observed for furanone C-30 32 (Costas et al., 2015). However, terrein 31 was found to decrease c-di-GMP levels; while furanone C-30 32 increased it. The study of Kim et al. suggested that the QS system controls the c-di-GMP levels by regulating the activity of DGCs and PDEs. DGC activity seemed to be regulated by Las-QS via LasR and PDE by Rhl-QS (Costas et al., 2015).
Substrate and/or Product Analogs
Another approach for development of enzyme inhibitors is based on compounds that mimic the electronic and/or geometric characteristics of the substrate(s) or product(s), inducing enzyme inhibition due to competitive binding or a negative feedback loop, respectively.
In 2011 Sintim et al. performed the first of many studies on analogs of c-di-GMP (Wang et al., 2011). They studied the two conformations (open and closed) of c-di-GMP (Figure 7) and investigated how changing the bridging heteroatom X could shift the equilibrium between the conformations. C-di-GMP binds to PDEs in an open conformation, while it binds to DGCs in a closed conformation as a dimer (Figure 7) (Wang et al., 2011). Therefore, developing c-di-GMP analogs that prefers an “open” vs. “closed” conformer could allow for a control of the binding affinity toward PDEs vs. DGCs.
Figure 7. Illustration of the open and closed conformation of X-modified c-di-GMP by Wang et al. (2011). (A) Without enzymes (B) with enzymes illustrated.
The study by Sintim et al. revealed that the sulfur-substituted analog endo-S-c-di-GMP 33 (Figure 8) that predominantly stay in an open form, selectively inhibited PDEs without affecting the potent P. aeruginosa DGC WspR. Although not directly relevant for inhibition of biofilm, the work nicely demonstrated that selective binding to specific classes of c-di-GMP binding proteins can be accomplished by altering conformer populations of the analog (so-called conformational steering). This could be utilized as design principle when developing selective PDE-activators or DGC-inhibitors that interfere with biofilm formation and/or persistence. Furthermore, as discussed previously, selective inhibition of some of the virulence-associated PDEs that do not regulate biofilm dispersal could be relevant for treatment of biofilm-associated infections.
Subsequently, the Sintim group expanded their studies of c-di-GMP analogs to include modification of the 2′-position of the ribose moiety (Zhou et al., 2012, 2013). Both analogs bridged with sulfur (Zhou et al., 2012) and oxygen (Zhou et al., 2013) were studied (see Figure 8). Biophysical characterization and comparison of relative energies showed that endo-S-c-di-GMP 33 and the flour-substituted endo-S-c-di-GMP analog (2′-F-endo-S-c-di-GMP 34c, Figure 8) preferred the closed form, whereas the methoxy-substituted 2′-OMe-endo-S-c-di-GMP 34a (Figure 8) preferred the open form. In comparison, the 2′-H-endo-S-c-di-GMP 34b (Figure 8) showed similar energies for both conformations. Sintim et al. then investigated the binding of the c-di-GMP analogs to a Vc2 RNA riboswitch. So far, two classes of riboswitches that binds c-di-GMP have been identified; the c-di-GMP-I riboswitch (class I) and c-di-GMP-II riboswitch (class II). The Vc2 RNA is a class I riboswitch, and crystal structure studies have shown that class I riboswitches bind c-di-GMP in the closed conformation. Of the new analogs, the flour-substituted 2′-F-endo-S-c-di-GMP 34c had the highest relative binding to the class I riboswitch. Although more enzyme-selective, the binding affinity was similar to the binding affinity of native c-di-GMP and endo-S-c-di-GMP 33 (Figure 8). The investigations showed that the 2′-position is essential for binding to the class I riboswitch, Vc2 RNA, which can be used to design analogs that only target specific c-di-GMP proteins.
Studying the ribose-modified analogs bridged with oxygen (Zhou et al., 2013) (Figure 8), Sintim et al. found that the 2′-F-substituted ribose analogs (c-di-2′F-GMP 35c) bind to the I-site of DGC four times better than c-di-GMP, while c-di-GMP bound 10 times better to PDEs than c-di-2′F-GMP 35c. Although, the c-di-2′F-GMP 35c was seen to still inhibit PDEs, their results showed the potential of designing selective DGC-inhibitors through investigation of I-site binders. The bulky 2′-OMe-substituted 35a analog was found to be a poor DGC-inhibitor, which they explained with lack of space in the binding pocket of the enzymes tested. The polarity reduced 2′-H-substituted analog 35b was shown to have similar binding-affinity as c-di-GMP.
Shanahan et al. (2013) also studied c-di-GMP analogs; here with the aim of identifying analogs that were resistant to hydrolysis by PDE, in order to apply them for riboswitch control. The different analogs studied are illustrated in Figure 9 and divided into two groups according to the modification; base modification (A, 36a-e) and ribose- and phosphate modification (B, ribose 37a-d, phosphate 38a-d, both 39a-b), respectively. The authors evaluated the rate of hydrolysis by PDE as compared to c-di-GMP. In the three categories base, ribose and phosphate, the latter gave the best overall results. They found that substitution of the phosphates with phosphorothioatea (e.g., c-(RpRp)-di-Gps 38c and c-(RpSp)-di-Gps, 38d, Figure 9) yielded analogs with good binding affinity toward both classes of riboswitches (Shanahan et al., 2011). Additionally the thio-substituted analogs showed good binding affinity toward the EAL domain without being degraded; indicating their potential as PDE-inhibitors.
Figure 9. C-di-GMP analogs studied by Shanahan et al. (2013) (A) base modification (36a-e) (B) ribose modification (37a-d), phosphate modification (38a-d), both ribose- and phosphate-modification (39a-b).
In 2015 Cutruzzolá et al. investigated c-di-GMP analogs to identify allosteric inhibitors of DGCs that does not affect PDEs (Fernicola et al., 2015). They synthesized and screened a series of 16 analogs where the phosphate/ribose moiety was replaced with a non-hydrolyzable 1,2,3-triazole. Different analogs were investigated with variation of the guanine base moiety (Scaffold A, Figure 10), as well as analogs where one (Scaffold B, Figure 10) or both (Scaffold C, Figure 10) of the two ribose-moieties was omitted. Of the tested analogs, the simple analog DCI061 43b (Scaffold C, Figure 10) showed good inhibition of the P. aeruginosa PDE; RocR. When further investigating the DCI061(43b)-scaffold, Fernicola et al. were able to draw some general conclusions: (1) Introducing bulky substituents in the guanine base, resulted in a dramatic loss of inhibitory activity toward RocR. (2) The electrophilic character of the substituent in the C-6 position proved to be crucial for binding to the inhibitory site of DGCs and anti-binding to the EAL active site (PDEs). (3) The 2-amino group in guanine is important for binding of DGC, while not crucial for binding to EAL. (4) The distance between the two purines was crucial, with a 3-carbon spacer resulting in optimal interaction, while both a 2- and 4-carbon spacer resulted in complete loss of inhibitory activity.
Figure 10. C-di-GMP analogs, with a 1,2,3-trizole moiety incorporated, investigated for their allosteric inhibitory effect on DGC by Cutruzzolá et al. The analogs are grouped into three Scaffold types (A–C; Fernicola et al., 2015).
Guanosin-tetraphosphate (ppGpp), i.e., phosphorylated analogs of GTP and GDP, is produced by the Rel proteins and accumulates in a variety of bacterial species as a stress response to amino acid starvation. Under these conditions amino acids are maintained and RNA synthesis is inhibited; causing, among other effects, low ability to sustain biofilm formation (Wexselblatt et al., 2010). Therefore, inhibition of the synthetic activity of Rel proteins may prevent bacteria from sensing conditions where amino-acids are absent in their environment, which, in turn, may ultimately lead to bacterial self-starvation and death. In 2010 Wexselblatt et al. studied ppGpp analogs (see Figure 11) (Wexselblatt et al., 2010), and tested them as competitive inhibitors of Rel proteins. Vidavski et al. observed that 2′-deoxyguanosine-3′-5′-di(methylene bisphosphonate) (40i, Figure 11) is a competitive binder for GTP in the Rel protein; causing inhibition of the protein and lowering of ppGpp production.
Figure 11. ppGpp analogs studied by Wexselblatt et al. (2010).
Inhibitors of QS in Pseudomonas aeruginosa and Acinetobacter baumannii
This section presents an overview of small molecules identified as QS inhibitors (QSIs) targeting P. aeruginosa and A. baumannii. QS inhibition is a way to attenuate pathogenicity without obstructing processes that are essential for bacterial growth. In this section we will focus on compounds targeting the AI-1 system used by both P. aeruginosa and A. baumannii and not cover molecules targeting the PQS system only used by P. aeruginosa. Several comprehensive reviews about QS inhibitors have been published, some of which focus on the biological activity of the compounds (Jakobsen et al., 2013, 2017a; Kalia, 2013) and others on the structures providing knowledge as to the molecular characteristics important for inhibition (Geske et al., 2008b; Galloway et al., 2011). P. aeruginosa is by far the most studied organism in relation to inhibition of AHL-mediated QS, whereas the number of studies investigating QS inhibition of A. baumannii is more limited.
The quest for small molecules capable of lowering the efficacies of QS systems has gained considerable attention for more than two decades, and it has resulted in the identification of a large variety of QS inhibitors. It has been shown that a QS-deficient P. aeruginosa biofilm established either by the use of QS deficient mutants or treatment with QS inhibitors shows a decrease in survival in a mouse lung infection model compared to a P. aeruginosa infection with a functional QS system (Wu et al., 2004; Bjarnsholt et al., 2005; Jakobsen et al., 2012b). Three factors that are most likely involved in this change in P. aeruginosa are rhamnolipids, extracellular DNA and pyocyanin. They are all partially or completely QS regulated and are shown to provide protection from host immunity as well as antibiotic therapy (Davey et al., 2003; Allesen-Holm et al., 2006; Jensen et al., 2007; Chiang et al., 2013; Das et al., 2015).
Modulators of AHL-Based QS Systems
A general perspective is that there are three targets to chemically affect AHL mediated QS systems by small molecules: (I) the signal production (LuxI-type synthase), (II) the signal molecule (AHL-ligand) and (III) the signal receptor (LuxR-type receptor) (Rasmussen and Givskov, 2006). However, this is a perspective with modifications and differences between the AHL QS systems in bacterial organisms exist. For instance, the AHL QS system in P. aeruginosa consists of two LuxIR-type systems, LasIR and RhlIR, which are interlinked, contrary to the QS system in A. baumannii which is based on only a single LuxIR system, AbaIR. The structure of the signal molecules employed by these QS systems is shown in Figure 12. In addition, the P. aeruginosa QS system is comprised of additional systems such as IQS and PQS connected to the Las and the Rhl system making the inhibition of the system more complex.
Figure 12. Structures of the AHL signal molecules produced by P. aeruginosa (44, 45) and A. baumannii (46).
Inhibition of the AHL synthase can be an effective strategy to disconnect cell to cell signaling, however at present there are very few studies with a thorough investigation of small molecules targeting the signal production. Studies have investigated the potential of using analogs of S-adenosylmethionine (SAM), which is the amino donor for the formation of the homoserine lactone ring moiety. Three analogs, S-adenosyl-homocysteine 47a, sinefungin 47b (Figure 13) and butyryl SAM have been shown to inhibit P. aeruginosa RhlI synthase and block AHL production in vitro (Parsek et al., 1999).
Targeting QS signaling directly by enzymatic degradation of the signal molecule can be achieved by an AHL-lactonase, AHL-acylase or a paraoxonase that break the AHL molecule or by oxidoreductases that reduce the carbonyl to a hydroxyl group (Chen et al., 2013). Several AHL-lactonases have been discovered to date including the enzyme MomL that was identified from Muricauda olearia Th120. MomL was shown to efficiently degrade a number of different AHLs (Tang et al., 2015). Recently, MomL was shown to reduce biofilm formation of P. aeruginosa and A. baumannii as well as to increase biofilm susceptibility to different antibiotics. However, no activity was detectable in a wound biofilm model or in a C. elegans model questioning the in vivo anti-QS effect of MomL (Zhang et al., 2017). AiiA lactonase isolated from the soil bacterium Bacillus sp. 240B1 was the first lactonase to be described (Dong et al., 2000). Later the AiiM lactonase was shown to be an effective inhibitor of P. aeruginosa QS and to reduce a P. aeruginosa infection in a mouse model of acute pneumonia (Migiyama et al., 2013). Paraoxonases (PON) has been identified in several different mammals. They have strong degradation activity toward the acylated chain of AHLs especially if the chain is long. The P. aeruginosa signal molecule 3-oxo-C12-HSL is effectively hydrolyzed by PON resulting in attenuation of the QS system (Chun et al., 2004; Yang et al., 2005; Teiber et al., 2008).
Most studies investigating QS inhibition by small molecules have been focused upon identification of compounds that interact and paralyze the LuxR-homolog receptor. By using AHL analogs that match the LuxR-homolog, a signal-receptor complex is generated that is competitive to the native active complex leading to disruption of signaling. Several studies have successfully identified a range of both QS activators and inhibitors by introducing changes to the lactone moiety or the acyl chain of the native signal molecules. The generated X-ray crystal structure of some LuxR-type receptors in a complex with their natural AHL ligands has given the opportunity to use this information in the design of synthetic AHL ligands. The crystal structure of the ligand-binding domain of LasR has been solved (Bottomley et al., 2007), whereas no structure of AbaR has been reported to date. In addition, to the search for AHL analogs there has been a significant effort to identify small molecules that are distinct from the native AHL molecules. The commonly used methods have been screening of random chemical libraries consisting of either natural products isolates or synthetic made compounds together with bioassay-guided fractionation of natural products.
Studies on AHL-Derived QS Modulators
Several comprehensive SAR analyses of synthetic non-natural AHL analogs targeting P. aeruginosa have been reported. In 2008 Geske et al. published a review that summarizes SARs for non-natural AHL analogs in a range of bacterial species (Geske et al., 2008b), while Spring et al. (Galloway et al., 2011) in 2011 published a SAR analysis on AHL QS modulators. Below is a short summary of the SAR trends highlighted in these reviews, and Figure 14 outlines the most potent inhibitors. Geske et al. delineated some broad activity trends for the AHL mimics (see below). These trends are highlighted with colored spheres in Figure 14 for AHL analogs found to inhibit QS in P. aeruginosa. Trend 1 concerns the length of the acyl chain, which in general have to be close to the length of the natural AHL to have high activity. Trend 2 and Trend 3 relate to the third carbon on the acyl chain, and in Trend 2 it is seen that a carbonyl group in this position is important for activity. However, the carbonyl is not essential, and Trend 3 summarizes AHL inhibitors that do not contain this carbonyl. Trend 4 highlights the importance of stereochemistry where the L-stereoisomer of the natural AHL lactone ring is important. However, studies investigating racemic mixtures has also resulted in identification of good inhibitors. Therefore, it is uncertain whether the L-isomer is the only active species. Trend 5 concerns modifications of the lactone ring, which has been shown to be tolerated in some systems but most often has led to a decrease in activity. Lastly, Trend 6 shows AHL inhibitors that incorporate aromatic functionalities either by replacing the lactone ring or as substituent on the acyl chain.
Figure 14. Collection of the most potential QS inhibitors mentioned in Geske et al. (2008b) and Galloway et al. (2011).  (Passador et al., 1996)  (Ishida et al., 2007)  (Smith et al., 2003a)  (Smith et al., 2003b)  (Jog et al., 2006)  (Geske et al., 2005)  (Geske et al., 2008a)  (Kim et al., 2009a), and  (Kim et al., 2009b).
In 2012 Stacy et al. published a SAR study of non-natural AHL analogues' ability to activate and inhibit A. baumannii QS by agonizing or antagonizing the AbaR receptor (Stacy et al., 2012). In general, the strongest AbaR antagonist contained aromatic acyl groups. Phenylacetanoyls homoserine lactones (PHLs) (55a) with substituents on the phenyl ring showed good antagonistic activity. Among the halogenated PHLs, antagonistic activity was found to increase with increasing size and decreasing electronegativity of the halogen. For example, the iodo PHLs (55b) was strongly inhibitory as the most active group followed by bromo and chloro being good to moderate inhibitors and fluoro PHLs being weakly inhibitory (Figure 15). Compounds containing substitutions in the 3-position of the PHL aromatic ring were found to generally show stronger inhibition, whereas inhibitor activity was lowered when substitutions were introduced in the 2- and 4-positions. A previous study reported a similar trend with non-native AHLs containing a PHL group showing antagonistic activity of the P. aeruginosa LasR protein (Geske et al., 2008c). Stacy et al. suggested that the mode of action of the investigated class of PHLs in LasR and AbaR could be similar (Stacy et al., 2012).
Figure 15. (A) General phenylacetyl HSL (PHL) (55a) and the most active PHL antagonist (55b) against AbaR (Stacy et al., 2012) and LasR (Geske et al., 2008c). (B) General phenylbutanoyl HSL (PBHL) (56a) and one of the most active PBHL antagonist (56b) against AbaR and LasR (Gerdt et al., 2017). (C) Structures of licoricone (57a), glycyrin (57b), glyzarin (57c) and flavan-3-ol catechin (57d). (D) Structure of ajoene (58a) and two additional inhibitory QSI inhibitors (58b and 58c) identified from a random screening by Fong et al. (2017). (E) Ajoene analogs synthesized by Fong et al. (2017). (F) Structures of iberin (60a), cheirolin (60b), iberverin (60c), sulforaphane (60d), alyssin (60e) (Jakobsen et al., 2012a), and erucin (60f) (Ganin et al., 2013) with QS inhibitory activity against P. aeruginosa.
Based on the activity of PHL described above, a recent study investigated two carbon extended N-(phenylbutanoyl) L-homoserine lactone (PBHL) ligands for inhibition of AbaR and LasR activity. The examined PBHL either contained unsubstituted or chlorine- or iodine-substituted phenyl groups and varied in the oxidation states of the 3-position (56a, Figure 15). It was reported that inhibition of LasR moderately depended on oxidation state, whereas AbaR inhibition was not significantly affected by the oxidation state of the PBHL ligand.
Studies on Non-AHL-Based QS Modulators
The mode of actions of non-AHL like QS inhibitory compounds have in many cases not been specified questioning which part of the QS system is targeted. Therefore, is it possible that some of the compounds presented in the following section do not target the QS system through modulation of the LuxR-type receptor specifically. In addition, there is often a considerable difference between the molecular structures of the identified QS inhibitors from various studies of non-AHL based QS modulators which limit the number of compounds to build adequate SAR studies. Nevertheless, the structures of the different identified QS inhibitors are relevant for further discussion of what might be potentially active compounds.
Some of the first identified and intensively studied QS inhibitors originating from natural sources were the brominated furanones. Since the bioactivity of furanones, extracted from the marine algae Delisea pulchra, was hypothesized to exert its activity by paralyzing the AHL regulated QS system (Givskov et al., 1996), several studies have investigated QS modulation activity of a great number of furanone derivatives. In 2003, the Givskov group delivered proof of concept regarding QS inhibition as an antimicrobial principle (Hentzer et al., 2003). With chemically modified halogenated furanones they showed a significant impact on QS controlled gene expression (first transcriptomic analyses to be undertaken), as well as decreases in QS regulated virulence factors, and accelerated clearance of P. aeruginosa in a lung infection mouse model (Hentzer et al., 2003; Wu et al., 2004). For a more detailed description of investigated furanones together with related structural analogs the reader is referred to Galloway et al. (2011).
Phytochemicals such as flavonoids, flavanones, polyphenols, furacoumarins, and hydrolysable tannins has been shown to disrupt the QS system in a number of different bacteria (Kalia et al., 2013). By bioassay guided fractionation of Glycyrrhiza glabra, commonly known as liquorice, a methanol extract was shown to inhibit motility and biofilm formation of A. baumannii. In addition, the production of 3-OH-C12-HSL was significantly reduced indicating disruption of the QS system. Q-TOF MS and Q-TRAP MS/MS analysis of the extract suggested the presence of the following three flavonoids; licoricone (57a), and glycyrin (57b) and glyzarin (57c) (Figure 15) (Bhargava et al., 2015). The flavonoid flavan-3-ol catechin (57d) extracted from the bark of Combrenum albiflorum has been reported to decrease the expression of P. aeruginosa QS regulated genes as well as to inhibit the production of QS regulated virulence factors (Vandeputte et al., 2010).
A number of sulfur containing compounds has been reported as QS inhibitors of P. aeruginosa. Ajoene 58a (Figure 15) from crushed garlic was reported to inhibit a subset of QS controlled genes including rhamnolipid production, and to increase the susceptibility of P. aeruginosa biofilms to tobramycin and significantly decrease P. aeruginosa infection in the lungs of mice (Jakobsen et al., 2012b). Ajoene displays its activity by lowering the expression of the two small RNAs RsmY and RsmZ located upstream of the central QS system in P. aeruginosa (Jakobsen et al., 2017b). From a random screening of a chemical compound library two sulfur containing compounds 58b and 58c (Figure 15) with structural similarities to ajoene were reported as QS inhibitors of P. aeruginosa (Fong et al., 2017). Both compounds share the same allylic disulphide bond with ajoene marked with a red dotted line in Figure 15.
Subsequently, syntheses of 25 disulphide bond-containing analogs were carried out to investigate the importance of the allyl disulphide group for bioactivity (Fong et al., 2017). The authors reported that the allyl group was not strictly important for QS activity, which was shown with the saturated analog 58b that displayed excellent QS inhibitory activity (Figure 15). A p-chlorophenyl derivative (59a) showed the highest QSI activity among the tested compounds, whereas the absence of disulphide bond diminished the QS inhibitory activity completely as shown with 59c in Figure 15. In addition, two compounds devoid of the benzothiazole functional group did not display any QS inhibitory activity. The two compounds 59b and 59a were reported to decrease production of the three important QS regulated virulence factors; elastase, pyocyanine, and rhamnolipid. In addition, both compounds significantly decreased P. aeruginosa bacterial counts in a foreign-body implant mouse model compared to an untreated control group. This relative small SAR analysis of ajoene analogs indicates that the presence of a disulphide bond is important for bioactivity. In addition, the presence of a benzothiazole moiety increases the QS inhibitory activity substantially compared with ajoene.
Additional sulfur containing compounds have been identified as QS inhibitors of P. aeruginosa. By means of bioassay-guided fractionation of horseradish, 1-isothiocyanato-3-(methylsulfinyl) propane, commonly known as iberin (60a, Figure 15) was identified as an efficient QS inhibitor of P. aeruginosa (Jakobsen et al., 2012a). Iberin 60a is a natural isothiocyanate with a sulfinyl group found in many members of the Brassicaceae family. Together with iberin 60a, the following four related structural isothiocyanate analogs was reported as inhibitors: cheirolin (60b), iberverin (60c), sulforaphane (60d) and alyssin (60e) (Figure 15), however, they all showed lower QS inhibitory activities than iberin 60a (IC50 values of ~2, 6, 10, and 30 times higher, respectively). Another study also reported sulforaphane to inhibit the QS system of P. aeruginosa together with the isothiocyanate erucin (60f, Figure 15) extracted from broccoli (Ganin et al., 2013).
Taken together, the number of different sulfur containing compounds that have been reported with excellent QS inhibitory activities makes it an interesting class of molecules to be studied further. The identified compounds have little structural similarity to native AHLs. This can be an advantage compared to AHL like compounds when considering that the homoserine lactone moiety is unstable at alkaline pH and potentially can be degraded by mammalian lactonases.
Conclusions and Perspectives
According to WHO and UN, antimicrobial resistance is rising to unmanageable levels in all parts of the world and has become a top global threat. This grim perspective is paralleled by the fact that only two new classes of antibiotics have been clinically approved over the past 30 years. So far, the majority of clinically approved antibiotics have been designed to efficiently kill free-living (planktonic), growing bacteria. In the environment however, the preferred life-mode of bacteria is as densely packed microcolonies concealed in a protective matrix of biopolymers that offer protection against the otherwise lethal action of a wide variety of environmental stressors including antimicrobials. In this biofilm life-mode, bacteria are also believed to cause a significant number of human microbial infections. Nosocomial infections are estimated to be the fourth leading cause of death in the U.S. with 2 million cases annually, and about 60–70% of these nosocomial infections are caused by bacterial biofilms (Bryers, 2008). Because of the general neglect of the biofilm-mode in past antibiotic development, the central problem with biofilm infections is that the involved bacteria are generally not susceptible to our present assortment of antibiotics. Adding to this the resistance to the antimicrobial activities of the immune system in general, the biofilm mode offers an almost unlimited capacity to survive in the infected host (Costerton et al., 1999; Rybtke et al., 2015).
With the increase in infectious diseases showing multiple resistances and the paralleled downsizing in antibiotic development there is, more than ever, an urgent need for development of antimicrobials with new and different modes of action. Such antimicrobials may be designed to include non-lethal targets associated with the biofilm life-mode, where the chemistry and mode of actions of some of those compounds have been reviewed in the present paper. Conceptually such drugs function to attenuate biofilm formation and/or pathogenicity without obstructing processes that are essential for bacterial growth and reproduction. Among the few identified targets are two key biofilm gateways; the one that controls the switch between the biofilm-planktonic life modes in responses to the internal levels of c-di-GMP, and QS which governs the production of virulence factors and some of the protective mechanisms operating in the biofilm mode. Proof of concept driven research initiated more than 20 years ago by us have shown the signaling gateways to be viable drug targets for a new class of what can generally be referred to as non-lethal antibiotics (Hentzer et al., 2003). It has been postulated, but not directly demonstrated, that such modes of drug action would reduce the selection pressure for resistant bacterial variants. While this may to a certain extent be correct for QS, we have unpublished experimental data showing that in an environment where biofilm formation promotes growth and provides a hold-fast of bacteria, chemical obstruction of biofilm formation raises a significant selection pressure for insensitive mutants and resistance seems to arise as frequently as it does to the action of conventional antibiotics.
We and others are currently in pursuit of the development of chemical compounds capable of preventing formation of biofilms. Most of the work done so far aims at targeting (inhibiting) c-di-GMP synthesis. One of the rationales for this is the highly conserved composition of the GGDEF domains in multiple Gram negative species. Aiming for this target would then be expected to result in development of broad spectrum anti-biofilm drugs. We have been following this strategy too, but with disappointing results. We are currently pursuing stimulation of PDE activities to accomplice a reduction in the cellular c-di-GMP content. This strategy comes from our findings that overexpression of an E. coli PDE (PdeH) in P. aeruginosa plummets the c-di-GMP level and results in massive biofilm dispersal (Christensen et al., 2013). This concept is functional in vivo as judged from our mouse implant model of infection (Christensen et al., 2013). However, success of this strategy depends on selection of the right PDE, since overexpression of some of the PDEs in P. aeruginosa evidently do not lead to biofilm dispersal (Chambers et al., 2017), which is in agreement with the emerging theme that DGCs, PDEs and c-di-GMP effectors often work via protein-protein interactions. Treatment of biofilm infections by means of large scale dispersal of bacteria from the biofilms, would require combinatorial treatments with conventional antibiotics that eradicate the dispersed bacteria.
Whereas, the success criteria for lethal antibiotics have largely been based on low MIC values, the process of designing non-lethal antibiotics that would in turn work in concert with their lethal counter parts is significantly more elaborative and challenging. As emphasized in this review, small molecules continue to emerge as efficient modulators of bacterial biofilm formation. An increasing number of new molecular scaffolds and chemotypes, derived from both natural products and of entirely synthetic origin, have been developed. The reported compounds are currently useful as tools to study the molecular mechanisms involved in biofilm formation, growth and dispersal, but may also serve as hits to guide early discovery efforts. There is academic and industrial consensus on the unique promise for translational applications, such as new antimicrobial medicines, anti-biofouling and crop protection agents, but the path forward for small-molecule biofilm modulation remains long. Driven by academic research efforts, it is only natural that most SAR studies have been balancing synthetic feasibility and in vitro studies as a prequel to devoted medicinal chemistry campaigns. For example, virtually no knowledge is available on the performance of biofilm modulating scaffolds in integrated ADME/TOX evaluation studies, pointing to all the usual challenges of small molecule drug discovery. As a further complication, a combination of poor assay standardization and studies on clinically irrelevant bacterial strains has significantly hampered target evaluation and drugability assessment. The biofilm scientific community must address the myriad of hard-to-reproduce biological data to leverage the value of the many novel compounds emerging from academic laboratories, and ultimately secure the fundamental basis of clinical translation.
All authors listed have made a substantial, direct and intellectual contribution to the work, and approved it for publication.
This work was supported by grants from the Danish Council for Independent Research, the Lundbeck Foundation, the Novo Nordisk Foundation, and the Carlsberg Foundation.
Conflict of Interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Åberg, V., Das, P., Chorell, E., Hedenstrom, M., Pinkner, J. S., Hultgren, S. J., et al. (2008). Carboxylic acid isosteres improve the activity of ring-fused 2-pyridones that inhibit pilus biogenesis in E. coli. Bioorg. Med. Chem. Lett. 18, 3536–3540. doi: 10.1016/j.bmcl.2008.05.020
Aberg, V., Hedenstrom, M., Pinkner, J. S., Hultgren, S. J., and Almqvist, F. (2005a). C-Terminal properties are important for ring-fused 2-pyridones that interfere with the chaperone function in uropathogenic E. coli. Org. Biomol. Chem. 3, 3886–3892. doi: 10.1039/b509376g
Aberg, V., Norman, F., Chorell, E., Westermark, A., Olofsson, A., Sauer-Eriksson, A. E., et al. (2005b). Microwave-assisted decarboxylation of bicyclic 2-pyridone scaffolds and identification of Abeta-peptide aggregation inhibitors. Org. Biomol. Chem. 3, 2817–2823. doi: 10.1039/b503294f
Alhede, M., Bjarnsholt, T., Jensen, P. O., Phipps, R. K., Moser, C., Christophersen, L., et al. (2009). Pseudomonas aeruginosa recognizes and responds aggressively to the presence of polymorphonuclear leukocytes. Microbiology 155, 3500–3508. doi: 10.1099/mic.0.031443-0
Allesen-Holm, M., Barken, K. B., Yang, L., Klausen, M., Webb, J. S., Kjelleberg, S., et al. (2006). A characterization of DNA release in Pseudomonas aeruginosa cultures and biofilms. Mol. Microbiol. 59, 1114–1128. doi: 10.1111/j.1365-2958.2005.05008.x
Anbazhagan, D., Mansor, M., Yan, G. O., Md Yusof, M. Y., Hassan, H., and Sekaran, S. D. (2012). Detection of quorum sensing signal molecules and identification of an autoinducer synthase gene among biofilm forming clinical isolates of Acinetobacter spp. PLoS ONE 7:e36696. doi: 10.1371/journal.pone.0036696
Anderson, G. G., Palermo, J. J., Schilling, J. D., Roth, R., Heuser, J., and Hultgren, S. J. (2003). Intracellular bacterial biofilm-like pods in urinary tract infections. Science 301, 105–107. doi: 10.1126/science.1084550
Antoniani, D., Bocci, P., Maciag, A., Raffaelli, N., and Landini, P. (2010). Monitoring of diguanylate cyclase activity and of cyclic-di-GMP biosynthesis by whole-cell assays suitable for high-throughput screening of biofilm inhibitors. Appl. Microbiol. Biotechnol. 85, 1095–1104. doi: 10.1007/s00253-009-2199-x
Antoniani, D., Rossi, E., Rinaldo, S., Bocci, P., Lolicato, M., Paiardini, A., et al. (2013). The immunosuppressive drug azathioprine inhibits biosynthesis of the bacterial signal molecule cyclic-di-GMP by interfering with intracellular nucleotide pool availability. Appl. Microbiol. Biotechnol. 97, 7325–7336. doi: 10.1007/s00253-013-4875-0
Barnhart, M. M., Sauer, F. G., Pinkner, J. S., and Hultgren, S. J. (2003). Chaperone-subunit-usher interactions required for donor strand exchange during bacterial pilus assembly. J. Bacteriol. 185, 2723–2730. doi: 10.1128/JB.185.9.2723-2730.2003
Barraud, N., Hassett, D. J., Hwang, S. H., Rice, S. A., Kjelleberg, S., and Webb, J. S. (2006). Involvement of nitric oxide in biofilm dispersal of Pseudomonas aeruginosa. J. Bacteriol. 188, 7344–7353. doi: 10.1128/JB.00779-06
Barraud, N., Schleheck, D., Klebensberger, J., Webb, J. S., Hassett, D. J., Rice, S. A., et al. (2009). Nitric oxide signaling in Pseudomonas aeruginosa biofilms mediates phosphodiesterase activity, decreased cyclic di-GMP levels, and enhanced dispersal. J. Bacteriol. 191, 7333–7342. doi: 10.1128/JB.00975-09
Ben Nasr, A., Olsen, A., Sjobring, U., Muller-Esterl, W., and Bjorck, L. (1996). Assembly of human contact phase proteins and release of bradykinin at the surface of curli-expressing Escherichia coli. Mol. Microbiol. 20, 927–935. doi: 10.1111/j.1365-2958.1996.tb02534.x
Besharova, O., Suchanek, V. M., Hartmann, R., Drescher, K., and Sourjik, V. (2016). Diversification of gene expression during formation of static submerged biofilms by Escherichia coli. Front. Microbiol. 7:1568. doi: 10.3389/fmicb.2016.01568
Bhargava, N., Singh, S. P., Sharma, A., Sharma, P., and Capalash, N. (2015). Attenuation of quorum sensing-mediated virulence of Acinetobacter baumannii by Glycyrrhiza glabra flavonoids. Future Microbiol. 10, 1953–1968. doi: 10.2217/fmb.15.107
Bjarnsholt, T., Jensen, P. O., Burmolle, M., Hentzer, M., Haagensen, J. A., Hougen, H. P., et al. (2005). Pseudomonas aeruginosa tolerance to tobramycin, hydrogen peroxide and polymorphonuclear leukocytes is quorum-sensing dependent. Microbiology 151, 373–383. doi: 10.1099/mic.0.27463-0
Boehm, A., Steiner, S., Zaehringer, F., Casanova, A., Hamburger, F., Ritz, D., et al. (2009). Second messenger signalling governs Escherichia coli biofilm induction upon ribosomal stress. Mol. Microbiol. 72, 1500–1516. doi: 10.1111/j.1365-2958.2009.06739.x
Borlee, B. R., Goldman, A. D., Murakami, K., Samudrala, R., Wozniak, D. J., and Parsek, M. R. (2010). Pseudomonas aeruginosa uses a cyclic-di-GMP-regulated adhesin to reinforce the biofilm extracellular matrix. Mol. Microbiol. 75, 827–842. doi: 10.1111/j.1365-2958.2009.06991.x
Bottomley, M. J., Muraglia, E., Bazzo, R., and Carfi, A. (2007). Molecular insights into quorum sensing in the human pathogen Pseudomonas aeruginosa from the structure of the virulence regulator LasR bound to its autoinducer. J. Biol. Chem. 282, 13592–13600. doi: 10.1074/jbc.M700556200
Brinton, C. C. Jr. (1965). The structure, function, synthesis and genetic control of bacterial pili and a molecular model for DNA and RNA transport in gram negative bacteria. Trans. N. Y. Acad. Sci. 27, 1003–1054. doi: 10.1111/j.2164-0947.1965.tb02342.x
Brombacher, E., Baratto, A., Dorel, C., and Landini, P. (2006). Gene expression regulation by the Curli activator CsgD protein: modulation of cellulose biosynthesis and control of negative determinants for microbial adhesion. J. Bacteriol. 188, 2027–2037. doi: 10.1128/JB.188.6.2027-2037.2006
Brombacher, E., Dorel, C., Zehnder, A. J., and Landini, P. (2003). The curli biosynthesis regulator CsgD co-ordinates the expression of both positive and negative determinants for biofilm formation in Escherichia coli. Microbiology 149, 2847–2857. doi: 10.1099/mic.0.26306-0
Brown, P. K., Dozois, C. M., Nickerson, C. A., Zuppardo, A., Terlonge, J., and Curtiss, R. III. (2001). MlrA, a novel regulator of curli (AgF) and extracellular matrix synthesis by Escherichia coli and Salmonella enterica serovar Typhimurium. Mol. Microbiol. 41, 349–363. doi: 10.1046/j.1365-2958.2001.02529.x
Cegelski, L., Pinkner, J. S., Hammer, N. D., Cusumano, C. K., Hung, C. S., Chorell, E., et al. (2009). Small-molecule inhibitors target Escherichia coli amyloid biogenesis and biofilm formation. Nat. Chem. Biol. 5, 913–919. doi: 10.1038/nchembio.242
Chambers, J. R., Cherny, K. E., and Sauer, K. (2017). Susceptibility of Pseudomonas aeruginosa dispersed cells to antimicrobial agents is dependent on the dispersion cue and class of the antimicrobial agent used. Antimicrob. Agents Chemother. 61:e00846–17. doi: 10.1128/AAC.00846-17
Chan, C., Paul, R., Samoray, D., Amiot, N. C., Giese, B., Jenal, U., et al. (2004). Structural basis of activity and allosteric control of diguanylate cyclase. Proc. Natl. Acad. Sci. U.S.A. 101, 17084–17089. doi: 10.1073/pnas.0406134101
Chapman, M. R., Robinson, L. S., Pinkner, J. S., Roth, R., Heuser, J., Hammar, M., et al. (2002). Role of Escherichia coli curli operons in directing amyloid fiber formation. Science 295, 851–855. doi: 10.1126/science.1067484
Chen, F., Gao, Y., Chen, X., Yu, Z., and Li, X. (2013). Quorum quenching enzymes and their application in degrading signal molecules to block quorum sensing-dependent infection. Int. J. Mol. Sci. 14, 17477–17500. doi: 10.3390/ijms140917477
Chiang, W. C., Nilsson, M., Jensen, P. O., Hoiby, N., Nielsen, T. E., Givskov, M., et al. (2013). Extracellular DNA shields against aminoglycosides in Pseudomonas aeruginosa biofilms. Antimicrob. Agents Chemother. 57, 2352–2361. doi: 10.1128/AAC.00001-13
Choi, A. H., Slamti, L., Avci, F. Y., Pier, G. B., and Maira-Litran, T. (2009). The pgaABCD locus of Acinetobacter baumannii encodes the production of poly-beta-1-6-N-acetylglucosamine, which is critical for biofilm formation. J. Bacteriol. 191, 5953–5963. doi: 10.1128/JB.00647-09
Chorell, E., Bengtsson, C., Sainte-Luce Banchelin, T., Das, P., Uvell, H., Sinha, A. K., et al. (2011). Synthesis and application of a bromomethyl substituted scaffold to be used for efficient optimization of anti-virulence activity. Eur. J. Med. Chem. 46, 1103–1116. doi: 10.1016/j.ejmech.2011.01.025
Chorell, E., Pinkner, J. S., Bengtsson, C., Banchelin, T. S., Edvinsson, S., Linusson, A., et al. (2012). Mapping pilicide anti-virulence effect in Escherichia coli, a comprehensive structure-activity study. Bioorg. Med. Chem. 20, 3128–3142. doi: 10.1016/j.bmc.2012.01.048
Chorell, E., Pinkner, J. S., Phan, G., Edvinsson, S., Buelens, F., Remaut, H., et al. (2010). Design and synthesis of C-2 substituted thiazolo and dihydrothiazolo ring-fused 2-pyridones: pilicides with increased antivirulence activity. J. Med. Chem. 53, 5690–5695. doi: 10.1021/jm100470t
Christensen, L. D., Van Gennip, M., Rybtke, M. T., Wu, H., Chiang, W. C., Alhede, M., et al. (2013). Clearance of Pseudomonas aeruginosa foreign-body biofilm infections through reduction of the cyclic Di-GMP level in the bacteria. Infect. Immun. 81, 2705–2713. doi: 10.1128/IAI.00332-13
Chun, C. K., Ozer, E. A., Welsh, M. J., Zabner, J., and Greenberg, E. P. (2004). Inactivation of a Pseudomonas aeruginosa quorum-sensing signal by human airway epithelia. Proc. Natl. Acad. Sci. U.S.A. 101, 3587–3590. doi: 10.1073/pnas.0308750101
Ciofu, O., and Tolker-Nielsen, T. (2019). Tolerance and Resistance of Pseudomonas aeruginosa Biofilms to Antimicrobial Agents-How P. aeruginosa can escape antibiotics. Front. Microbiol. 10:913. doi: 10.3389/fmicb.2019.00913
Costas, C., López-Puente, V., Bodelón, G., González-Bello, C., Pérez-Juste, J., Pastoriza-Santos, I., et al. (2015). Using surface enhanced raman scattering to analyze the interactions of protein receptors with bacterial quorum sensing modulators. ACS Nano 9, 5567–5576. doi: 10.1021/acsnano.5b01800
Cusumano, C. K., Pinkner, J. S., Han, Z., Greene, S. E., Ford, B. A., Crowley, J. R., et al. (2011). Treatment and prevention of urinary tract infection with orally active FimH inhibitors. Sci. Transl. Med. 3:109ra115. doi: 10.1126/scitranslmed.3003021
Danese, P. N., Pratt, L. A., Dove, S. L., and Kolter, R. (2000). The outer membrane protein, antigen 43, mediates cell-to-cell interactions within Escherichia coli biofilms. Mol. Microbiol. 37, 424–432. doi: 10.1046/j.1365-2958.2000.02008.x
Das, T., Kutty, S. K., Tavallaie, R., Ibugo, A. I., Panchompoo, J., Sehar, S., et al. (2015). Phenazine virulence factor binding to extracellular DNA is important for Pseudomonas aeruginosa biofilm formation. Sci. Rep. 5:8398. doi: 10.1038/srep08398
Davey, M. E., Caiazza, N. C., and O'toole, G. A. (2003). Rhamnolipid surfactant production affects biofilm architecture in Pseudomonas aeruginosa PAO1. J. Bacteriol. 185, 1027–1036. doi: 10.1128/JB.185.3.1027-1036.2003
Deziel, E., Comeau, Y., and Villemur, R. (2001). Initiation of biofilm formation by Pseudomonas aeruginosa 57RP correlates with emergence of hyperpiliated and highly adherent phenotypic variants deficient in swimming, swarming, and twitching motilities. J. Bacteriol. 183, 1195–1204. doi: 10.1128/JB.183.4.1195-1204.2001
Diggle, S. P., Cornelis, P., Williams, P., and Camara, M. (2006a). 4-quinolone signalling in Pseudomonas aeruginosa: old molecules, new perspectives. Int. J. Med. Microbiol. 296, 83–91. doi: 10.1016/j.ijmm.2006.01.038
Diggle, S. P., Stacey, R. E., Dodd, C., Camara, M., Williams, P., and Winzer, K. (2006b). The galactophilic lectin, LecA, contributes to biofilm development in Pseudomonas aeruginosa. Environ. Microbiol. 8, 1095–1104. doi: 10.1111/j.1462-2920.2006.001001.x
Dong, Y. H., Xu, J. L., Li, X. Z., and Zhang, L. H. (2000). AiiA, an enzyme that inactivates the acylhomoserine lactone quorum-sensing signal and attenuates the virulence of Erwinia carotovora. Proc. Natl. Acad. Sci. U.S.A. 97, 3526–3531. doi: 10.1073/pnas.97.7.3526
Dorsey, C. W., Tomaras, A. P., and Actis, L. A. (2002). Genetic and phenotypic analysis of Acinetobacter baumannii insertion derivatives generated with a transposome system. Appl. Environ. Microbiol. 68, 6353–6360. doi: 10.1128/AEM.68.12.6353-6360.2002
Dueholm, M. S., Sondergaard, M. T., Nilsson, M., Christiansen, G., Stensballe, A., Overgaard, M. T., et al. (2013). Expression of Fap amyloids in Pseudomonas aeruginosa, P. fluorescens, and P. putida results in aggregation and increased biofilm formation. Microbiologyopen 2, 365–382. doi: 10.1002/mbo3.81
Emtenas, H., Åhlin, K., Pinkner, J. S., Hultgren, S. J., and Almqvist, F. (2002). Design and parallel solid-phase synthesis of ring-fused 2-pyridinones that target pilus biogenesis in pathogenic bacteria. J. Comb. Chem. 4, 630–639. doi: 10.1021/cc020032d
Emtenäs, H., Carlsson, M., Pinkner, J. S., Hultgren, S. J., and Almqvist, F. (2003a). Stereoselective synthesis of optically active bicyclic β-lactam carboxylic acids that target pilus biogenesis in pathogenic bacteriaElectronic supplementary information (ESI) available: 13C NMR spectra of 7(a–g), 10–14, 16(a and d) and 17(a–b). See http://www.rsc.org/suppdata/ob/b2/b210551a. Organ. Biomol. Chem. 1, 1308–1314. doi: 10.1039/b210551a
Emtenäs, H., Taflin, C., and Almqvist, F. (2003b). Efficient microwave assisted synthesis of optically active bicyclic 2-pyridinones via Δ2-thiazolines. Mol. Divers. 7, 165–169. doi: 10.1023/B:MODI.0000006800.46154.99
Fazli, M., Almblad, H., Rybtke, M. L., Givskov, M., Eberl, L., and Tolker-Nielsen, T. (2014). Regulation of biofilm formation in Pseudomonas and Burkholderia species. Environ. Microbiol. 16, 1961–1981. doi: 10.1111/1462-2920.12448
Fernicola, S., Paiardini, A., Giardina, G., Rampioni, G., Leoni, L., Cutruzzola, F., et al. (2016). in silico discovery and in vitro validation of catechol-containing sulfonohydrazide compounds as potent inhibitors of the diguanylate cyclase PleD. J. Bacteriol. 198, 147–156. doi: 10.1128/JB.00742-15
Fernicola, S., Torquati, I., Paiardini, A., Giardina, G., Rampioni, G., Messina, M., et al. (2015). Synthesis of triazole-linked analogues of c-di-GMP and their interactions with diguanylate cyclase. J. Med. Chem. 58, 8269–8284. doi: 10.1021/acs.jmedchem.5b01184
Fong, J., Yuan, M., Jakobsen, T. H., Mortensen, K. T., Delos Santos, M. M., Chua, S. L., et al. (2017). Disulfide bond-containing ajoene analogues as novel quorum sensing inhibitors of Pseudomonas aeruginosa. J. Med. Chem. 60, 215–227. doi: 10.1021/acs.jmedchem.6b01025
Gaddy, J. A., Tomaras, A. P., and Actis, L. A. (2009). The Acinetobacter baumannii 19606 OmpA protein plays a role in biofilm formation on abiotic surfaces and in the interaction of this pathogen with eukaryotic cells. Infect. Immun. 77, 3150–3160. doi: 10.1128/IAI.00096-09
Galloway, W. R., Hodgkinson, J. T., Bowden, S. D., Welch, M., and Spring, D. R. (2011). Quorum sensing in Gram-negative bacteria: small-molecule modulation of AHL and AI-2 quorum sensing pathways. Chem. Rev. 111, 28–67. doi: 10.1021/cr100109t
Ganin, H., Rayo, J., Amara, N., Levy, N., Krief, P., and Meijler, M. M. (2013). Sulforaphane and erucin, natural isothiocyanates from broccoli, inhibit bacterial quorum sensing. Medchemcomm 4, 175–179. doi: 10.1039/C2MD20196H
Gerdt, J. P., Wittenwyler, D. M., Combs, J. B., Boursier, M. E., Brummond, J. W., Xu, H., et al. (2017). Chemical interrogation of LuxR-type quorum sensing receptors reveals new insights into receptor selectivity and the potential for interspecies bacterial signaling. ACS Chem. Biol. 12, 2457–2464. doi: 10.1021/acschembio.7b00458
Geske, G. D., Mattmann, M. E., and Blackwell, H. E. (2008a). Evaluation of a focused library of N-aryl L-homoserine lactones reveals a new set of potent quorum sensing modulators. Bioorg. Med. Chem. Lett. 18, 5978–5981. doi: 10.1016/j.bmcl.2008.07.089
Geske, G. D., O'neill, J. C., and Blackwell, H. E. (2008b). Expanding dialogues: from natural autoinducers to non-natural analogues that modulate quorum sensing in Gram-negative bacteria. Chem. Soc. Rev. 37, 1432–1447. doi: 10.1039/b703021p
Geske, G. D., O'neill, J. C., Miller, D. M., Wezeman, R. J., Mattmann, M. E., Lin, Q., et al. (2008c). Comparative analyses of N-acylated homoserine lactones reveal unique structural features that dictate their ability to activate or inhibit quorum sensing. Chembiochem 9, 389–400. doi: 10.1002/cbic.200700551
Geske, G. D., Wezeman, R. J., Siegel, A. P., and Blackwell, H. E. (2005). Small molecule inhibitors of bacterial quorum sensing and biofilm formation. J. Am. Chem. Soc. 127, 12762–12763. doi: 10.1021/ja0530321
Givskov, M., De Nys, R., Manefield, M., Gram, L., Maximilien, R., Eberl, L., et al. (1996). Eukaryotic interference with homoserine lactone-mediated prokaryotic signalling. J. Bacteriol. 178, 6618–6622. doi: 10.1128/jb.178.22.6618-6622.1996
Gjermansen, M., Nilsson, M., Yang, L., and Tolker-Nielsen, T. (2010). Characterization of starvation-induced dispersion in Pseudomonas putida biofilms: genetic elements and molecular mechanisms. Mol. Microbiol. 75, 815–826. doi: 10.1111/j.1365-2958.2009.06793.x
Gjermansen, M., Ragas, P., and Tolker-Nielsen, T. (2006). Proteins with GGDEF and EAL domains regulate Pseudomonas putida biofilm formation and dispersal. FEMS Microbiol. Lett. 265, 215–224. doi: 10.1111/j.1574-6968.2006.00493.x
Gong, M., and Makowski, L. (1992). Helical structure of P pili from Escherichia coli. Evidence from X-ray fiber diffraction and scanning transmission electron microscopy. J. Mol. Biol. 228, 735–742. doi: 10.1016/0022-2836(92)90860-M
Hammar, M., Bian, Z., and Normark, S. (1996). Nucleator-dependent intercellular assembly of adhesive curli organelles in Escherichia coli. Proc. Natl. Acad. Sci. U.S.A. 93, 6562–6566. doi: 10.1073/pnas.93.13.6562
Hammar, M. R., Arnqvist, A., Bian, Z., Olsen, A., and Normark, S. (1995). Expression of two csg operons is required for production of fibronectin- and Congo red-binding curli polymers in Escherichia coli K-12. Mol. Microbiol. 18, 661–670. doi: 10.1111/j.1365-2958.1995.mmi_18040661.x
Han, Z., Pinkner, J. S., Ford, B., Obermann, R., Nolan, W., Wildman, S. A., et al. (2010). Structure-based drug design and optimization of mannoside bacterial FimH antagonists. J. Med. Chem. 53, 4779–4792. doi: 10.1021/jm100438s
Hedenstrom, M., Emtenas, H., Pemberton, N., Aberg, V., Hultgren, S. J., Pinkner, J. S., et al. (2005). NMR studies of interactions between periplasmic chaperones from uropathogenic E. coli and pilicides that interfere with chaperone function and pilus assembly. Org. Biomol. Chem. 3, 4193–4200. doi: 10.1039/b511857c
Hengge, R., Galperin, M. Y., Ghigo, J. M., Gomelsky, M., Green, J., Hughes, K. T., et al. (2016). Systematic nomenclature for GGDEF and EAL domain-containing Cyclic Di-GMP turnover proteins of Escherichia coli. J. Bacteriol. 198, 7–11. doi: 10.1128/JB.00424-15
Hentzer, M., Wu, H., Andersen, J. B., Riedel, K., Rasmussen, T. B., Bagge, N., et al. (2003). Attenuation of Pseudomonas aeruginosa virulence by quorum sensing inhibitors. EMBO J. 22, 3803–3815. doi: 10.1093/emboj/cdg366
Ishida, T., Ikeda, T., Takiguchi, N., Kuroda, A., Ohtake, H., and Kato, J. (2007). Inhibition of quorum sensing in Pseudomonas aeruginosa by N-acyl cyclopentylamides. Appl. Environ. Microbiol. 73, 3183–3188. doi: 10.1128/AEM.02233-06
Jakobsen, T. H., Bjarnsholt, T., Jensen, P. O., Givskov, M., and Hoiby, N. (2013). Targeting quorum sensing in Pseudomonas aeruginosa biofilms: current and emerging inhibitors. Future Microbiol. 8, 901–921. doi: 10.2217/fmb.13.57
Jakobsen, T. H., Bragason, S. K., Phipps, R. K., Christensen, L. D., Van Gennip, M., Alhede, M., et al. (2012a). Food as a source for quorum sensing inhibitors: iberin from horseradish revealed as a quorum sensing inhibitor of Pseudomonas aeruginosa. Appl. Environ. Microbiol. 78, 2410–2421. doi: 10.1128/AEM.05992-11
Jakobsen, T. H., Van Gennip, M., Phipps, R. K., Shanmugham, M. S., Christensen, L. D., Alhede, M., et al. (2012b). Ajoene, a sulfur-rich molecule from garlic, inhibits genes controlled by quorum sensing. Antimicrob. Agents Chemother. 56, 2314–2325. doi: 10.1128/AAC.05919-11
Jakobsen, T. H., Warming, A. N., Vejborg, R. M., Moscoso, J. A., Stegger, M., Lorenzen, F., et al. (2017b). A broad range quorum sensing inhibitor working through sRNA inhibition. Sci. Rep. 7:9857. doi: 10.1038/s41598-017-09886-8
Jennings, L. K., Storek, K. M., Ledvina, H. E., Coulon, C., Marmont, L. S., Sadovskaya, I., et al. (2015). Pel is a cationic exopolysaccharide that cross-links extracellular DNA in the Pseudomonas aeruginosa biofilm matrix. Proc. Natl. Acad. Sci. U.S.A. 112, 11353–11358. doi: 10.1073/pnas.1503058112
Jensen, P. O., Bjarnsholt, T., Phipps, R., Rasmussen, T. B., Calum, H., Christoffersen, L., et al. (2007). Rapid necrotic killing of polymorphonuclear leukocytes is caused by quorum-sensing-controlled production of rhamnolipid by Pseudomonas aeruginosa. Microbiology 153, 1329–1338. doi: 10.1099/mic.0.2006/003863-0
Jonas, K., Edwards, A. N., Simm, R., Romeo, T., Romling, U., and Melefors, O. (2008). The RNA binding protein CsrA controls cyclic di-GMP metabolism by directly regulating the expression of GGDEF proteins. Mol. Microbiol. 70, 236–257. doi: 10.1111/j.1365-2958.2008.06411.x
Justice, S. S., Hung, C., Theriot, J. A., Fletcher, D. A., Anderson, G. G., Footer, M. J., et al. (2004). Differentiation and developmental pathways of uropathogenic Escherichia coli in urinary tract pathogenesis. Proc. Natl. Acad. Sci. U.S.A. 101, 1333–1338. doi: 10.1073/pnas.0308125100
Kalia, D., Merey, G., Nakayama, S., Zheng, Y., Zhou, J., Luo, Y., et al. (2013). Nucleotide, c-di-GMP, c-di-AMP, cGMP, cAMP, (p)ppGpp signaling in bacteria and implications in pathogenesis. Chem. Soc. Rev. 42, 305–341. doi: 10.1039/C2CS35206K
Kang, D., and Kirienko, N. V. (2017). High-throughput genetic screen reveals that early attachment and biofilm formation are necessary for full pyoverdine production by Pseudomonas aeruginosa. Front. Microbiol. 8:1707. doi: 10.3389/fmicb.2017.01707
Karlsson, K. F., Walse, B., Drakenberg, T., Roy, S., Bergquist, K., Pinkner, J. S., et al. (1998). Binding of peptides in solution by the Escherichia coli Chaperone PapD as revealed using an inhibition ELISA and NMR spectroscopy. Bioorgan. Med. Chem. 6, 2085–2101. doi: 10.1016/S0968-0896(98)00162-X
Kikuchi, T., Mizunoe, Y., Takade, A., Naito, S., and Yoshida, S. (2005). Curli fibers are required for development of biofilm architecture in Escherichia coli K-12 and enhance bacterial adherence to human uroepithelial cells. Microbiol. Immunol. 49, 875–884. doi: 10.1111/j.1348-0421.2005.tb03678.x
Kim, B., Park, J. S., Choi, H. Y., Yoon, S. S., and Kim, W. G. (2018). Terrein is an inhibitor of quorum sensing and c-di-GMP in Pseudomonas aeruginosa: a connection between quorum sensing and c-di-GMP. Sci. Rep. 8:8617. doi: 10.1038/s41598-018-26974-5
Kim, C., Kim, J., Park, H. Y., Lee, J. H., Park, H. J., Kim, C. K., et al. (2009a). Structural understanding of quorum-sensing inhibitors by molecular modeling study in Pseudomonas aeruginosa. Appl. Microbiol. Biotechnol. 83, 1095–1103. doi: 10.1007/s00253-009-1954-3
Kim, C., Kim, J., Park, H. Y., Park, H. J., Kim, C. K., Yoon, J., et al. (2009b). Development of inhibitors against TraR quorum-sensing system in Agrobacterium tumefaciens by molecular modeling of the ligand-receptor interaction. Mol. Cells 28, 447–453. doi: 10.1007/s10059-009-0144-6
Kohanski, M. A., Dwyer, D. J., Hayete, B., Lawrence, C. A., and Collins, J. J. (2007). A common mechanism of cellular death induced by bactericidal antibiotics. Cell 130, 797–810. doi: 10.1016/j.cell.2007.06.049
Korea, C. G., Ghigo, J. M., and Beloin, C. (2011). The sweet connection: Solving the riddle of multiple sugar-binding fimbrial adhesins in Escherichia coli: multiple E. coli fimbriae form a versatile arsenal of sugar-binding lectins potentially involved in surface-colonisation and tissue tropism. Bioessays 33, 300–311. doi: 10.1002/bies.201000121
Kulasakara, H., Lee, V., Brencic, A., Liberati, N., Urbach, J., Miyata, S., et al. (2006). Analysis of Pseudomonas aeruginosa diguanylate cyclases and phos-phodiesterases reveals a role for bis-(3′-5′)-cyclic-GMP in virululence. Proc. Natl. Acad. Sci. U.S.A. 103, 2839–2844. doi: 10.1073/pnas.0511090103
Langermann, S., Palaszynski, S., Barnhart, M., Auguste, G., Pinkner, J. S., Burlein, J., et al. (1997). Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination. Science 276, 607–611. doi: 10.1126/science.276.5312.607
Lee, H. W., Koh, Y. M., Kim, J., Lee, J. C., Lee, Y. C., Seol, S. Y., et al. (2008). Capacity of multidrug-resistant clinical isolates of Acinetobacter baumannii to form biofilm and adhere to epithelial cell surfaces. Clin. Microbiol. Infect. 14, 49–54. doi: 10.1111/j.1469-0691.2007.01842.x
Lieberman, O. J., Orr, M. W., Wang, Y., and Lee, V. T. (2014). High-throughput screening using the differential radial capillary action of ligand assay identifies ebselen as an inhibitor of diguanylate cyclases. ACS Chem. Biol. 9, 183–192. doi: 10.1021/cb400485k
Liou, M. L., Soo, P. C., Ling, S. R., Kuo, H. Y., Tang, C. Y., and Chang, K. C. (2014). The sensor kinase BfmS mediates virulence in Acinetobacter baumannii. J. Microbiol. Immunol. Infect. 47, 275–281. doi: 10.1016/j.jmii.2012.12.004
Loehfelm, T. W., Luke, N. R., and Campagnari, A. A. (2008). Identification and characterization of an Acinetobacter baumannii biofilm-associated protein. J. Bacteriol. 190, 1036–1044. doi: 10.1128/JB.01416-07
Lopez, M., Mayer, C., Fernandez-Garcia, L., Blasco, L., Muras, A., Ruiz, F. M., et al. (2017). Quorum sensing network in clinical strains of A. baumannii: AidA is a new quorum quenching enzyme. PLoS ONE 12:e0174454. doi: 10.1371/journal.pone.0174454
Luo, L. M., Wu, L. J., Xiao, Y. L., Zhao, D., Chen, Z. X., Kang, M., et al. (2015). Enhancing pili assembly and biofilm formation in Acinetobacter baumannii ATCC19606 using non-native acyl-homoserine lactones. BMC Microbiol. 15:62. doi: 10.1186/s12866-015-0397-5
Ma, L., Conover, M., Lu, H., Parsek, M. R., Bayles, K., and Wozniak, D. J. (2009). Assembly and development of the Pseudomonas aeruginosa biofilm matrix. PLoS Pathog. 5:e1000354. doi: 10.1371/journal.ppat.1000354
Ma, L., Jackson, K. D., Landry, R. M., Parsek, M. R., and Wozniak, D. J. (2006). Analysis of Pseudomonas aeruginosa conditional psl variants reveals roles for the psl polysaccharide in adhesion and maintaining biofilm structure postattachment. J. Bacteriol. 188, 8213–8221. doi: 10.1128/JB.01202-06
Migiyama, Y., Kaneko, Y., Yanagihara, K., Morohoshi, T., Morinaga, Y., Nakamura, S., et al. (2013). Efficacy of AiiM, an N-acylhomoserine lactonase, against Pseudomonas aeruginosa in a mouse model of acute pneumonia. Antimicrob. Agents Chemother. 57, 3653–3658. doi: 10.1128/AAC.00456-13
Modarresi, F., Azizi, O., Shakibaie, M. R., Motamedifar, M., Mosadegh, E., and Mansouri, S. (2015). Iron limitation enhances acyl homoserine lactone (AHL) production and biofilm formation in clinical isolates of Acinetobacter baumannii. Virulence 6, 152–161. doi: 10.1080/21505594.2014.1003001
Mulvey, M. A., Lopez-Boado, Y. S., Wilson, C. L., Roth, R., Parks, W. C., Heuser, J., et al. (1998). Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli. Science 282, 1494–1497. doi: 10.1126/science.282.5393.1494
Niba, E. T., Naka, Y., Nagase, M., Mori, H., and Kitakawa, M. (2007). A genome-wide approach to identify the genes involved in biofilm formation in E. coli. DNA Res. 14, 237–246. doi: 10.1093/dnares/dsm024
Niu, C., Clemmer, K. M., Bonomo, R. A., and Rather, P. N. (2008). Isolation and characterization of an autoinducer synthase from Acinetobacter baumannii. J. Bacteriol. 190, 3386–3392. doi: 10.1128/JB.01929-07
Opoku-Temeng, C., and Sintim, H. O. (2017). “Targeting c-di-GMP signaling, biofilm formation, and bacterial motility with small molecules,” in c-di-GMP Signaling, Methods and Protocols, ed K. Sauer (New York, NY: Humana Press), 419–430. doi: 10.1007/978-1-4939-7240-1_31
O'Toole, G. A., and Kolter, R. (1998). Flagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development. Mol. Microbiol. 30, 295–304. doi: 10.1046/j.1365-2958.1998.01062.x
Parsek, M. R., Val, D. L., Hanzelka, B. L., Cronan, J. E. Jr., and Greenberg, E. P. (1999). Acyl homoserine-lactone quorum-sensing signal generation. Proc. Natl. Acad. Sci. U.S.A. 96, 4360–4365. doi: 10.1073/pnas.96.8.4360
Passador, L., Tucker, K. D., Guertin, K. R., Journet, M. P., Kende, A. S., and Iglewski, B. H. (1996). Functional analysis of the Pseudomonas aeruginosa Autoinducer PAI. J. Bacteriol. 178, 5995–6000. doi: 10.1128/jb.178.20.5995-6000.1996
Pemberton, N., Pinkner, J. S., Edvinsson, S., Hultgren, S. J., and Almqvist, F. (2008). Synthesis and evaluation of dihydroimidazolo and dihydrooxazolo ring-fused 2-pyridones—targeting pilus biogenesis in uropathogenic bacteria. Tetrahedron 64, 9368–9376. doi: 10.1016/j.tet.2008.07.015
Pesavento, C., Becker, G., Sommerfeldt, N., Possling, A., Tschowri, N., Mehlis, A., et al. (2008). Inverse regulatory coordination of motility and curli-mediated adhesion in Escherichia coli. Genes Dev. 22, 2434–2446. doi: 10.1101/gad.475808
Pinkner, J. S., Remaut, H., Buelens, F., Miller, E., Åberg, V., Pemberton, N., et al. (2006). Rationally designed small compounds inhibit pilus biogenesis in uropathogenic bacteria. Proc. Natl. Acad. Sci. U.S.A. 103, 17897–17902. doi: 10.1073/pnas.0606795103
Pratt, L. A., and Kolter, R. (1998). Genetic analysis of Escherichia coli biofilm formation: roles of flagella, motility, chemotaxis and type I pili. Mol. Microbiol. 30, 285–293. doi: 10.1046/j.1365-2958.1998.01061.x
Prigent-Combaret, C., Prensier, G., Le Thi, T. T., Vidal, O., Lejeune, P., and Dorel, C. (2000). Developmental pathway for biofilm formation in curli-producing Escherichia coli strains: role of flagella, curli and colanic acid. Environ. Microbiol. 2, 450–464. doi: 10.1046/j.1462-2920.2000.00128.x
Rakshit, S., and Sivasankar, S. (2014). Biomechanics of cell adhesion: how force regulates the lifetime of adhesive bonds at the single molecule level. Phys. Chem. Chem. Phys. 16, 2211–2223. doi: 10.1039/c3cp53963f
Rose, R. J., Verger, D., Daviter, T., Remaut, H., Paci, E., Waksman, G., et al. (2008). Unraveling the molecular basis of subunit specificity in P pilus assembly by mass spectrometry. Proc. Natl. Acad. Sci. U.S.A. 105, 12873–12878. doi: 10.1073/pnas.0802177105
Rosen, D. A., Hooton, T. M., Stamm, W. E., Humphrey, P. A., and Hultgren, S. J. (2007). Detection of intracellular bacterial communities in human urinary tract infection. PLoS Med. 4:e329. doi: 10.1371/journal.pmed.0040329
Rosen, D. A., Pinkner, J. S., Walker, J. N., Elam, J. S., Jones, J. M., and Hultgren, S. J. (2008). Molecular variations in Klebsiella pneumoniae and Escherichia coli FimH affect function and pathogenesis in the urinary tract. Infect. Immun. 76, 3346–3356. doi: 10.1128/IAI.00340-08
Rybtke, M., Hultqvist, L. D., Givskov, M., and Tolker-Nielsen, T. (2015). Pseudomonas aeruginosa biofilm infections: community structure, antimicrobial tolerance and immune response. J. Mol. Biol. 427, 3628–3645. doi: 10.1016/j.jmb.2015.08.016
Sahu, P. K., Iyer, P. S., Oak, A. M., Pardesi, K. R., and Chopade, B. A. (2012). Characterization of eDNA from the clinical strain Acinetobacter baumannii AIIMS 7 and its role in biofilm formation. ScientificWorldJournal. 2012:973436. doi: 10.1100/2012/973436
Sambanthamoorthy, K., Luo, C., Pattabiraman, N., Feng, X., Koestler, B., Waters, C. M., et al. (2014). Identification of small molecules inhibiting diguanylate cyclases to control bacterial biofilm development. Biofouling 30, 17–28. doi: 10.1080/08927014.2013.832224
Sambanthamoorthy, K., Sloup, R. E., Parashar, V., Smith, J. M., Kim, E. E., Semmelhack, M. F., et al. (2012). Identification of small molecules that antagonize diguanylate cyclase enzymes to inhibit biofilm formation. Antimicrob. Agents Chemother. 56, 5202–5211. doi: 10.1128/AAC.01396-12
Sarenko, O., Klauck, G., Wilke, F. M., Pfiffer, V., Richter, A. M., Herbst, S., et al. (2017). More than enzymes that make or break cyclic Di-GMP-local signaling in the interactome of GGDEF/EAL domain proteins of Escherichia coli. MBio 8:e01639–17. doi: 10.1128/mBio.01639-17
Schmidt, A. J., Ryjenkov, D. A., and Gomelsky, M. (2005). The ubiquitous protein domain EAL is a cyclic diguanylate-specific phosphodiesterase: enzymatically active and inactive EAL domains. J. Bacteriol. 187, 4774–4781. doi: 10.1128/JB.187.14.4774-4781.2005
Shanahan, C. A., Gaffney, B. L., Jones, R. A., and Strobel, S. A. (2011). Differential analogue binding by two classes of c-di-GMP riboswitches. J. Am. Chem. Soc. 133, 15578–15592. doi: 10.1021/ja204650q
Shanahan, C. A., Gaffney, B. L., Jones, R. A., and Strobel, S. A. (2013). Identification of c-di-GMP derivatives resistant to an EAL domain phosphodiesterase. Biochemistry 52, 365–377. doi: 10.1021/bi301510v
Simm, R., Morr, M., Kader, A., Nimtz, M., and Romling, U. (2004). GGDEF and EAL domains inversely regulate cyclic di-GMP levels and transition from sessility to motility. Mol. Microbiol. 53, 1123–1134. doi: 10.1111/j.1365-2958.2004.04206.x
Smith, K. M., Bu, Y., and Suga, H. (2003a). Induction and inhibition of Pseudomonas aeruginosa quorum sensing by synthetic autoinducer analogs. Chem. Biol. 10, 81–89. doi: 10.1016/S1074-5521(03)00002-4
Smith, K. M., Bu, Y., and Suga, H. (2003b). Library screening for synthetic agonists and antagonists of a Pseudomonas aeruginosa autoinducer. Chem. Biol. 10, 563–571. doi: 10.1016/S1074-5521(03)00107-8
Soto, S. M., Smithson, A., Horcajada, J. P., Martinez, J. A., Mensa, J. P., and Vila, J. (2006). Implication of biofilm formation in the persistence of urinary tract infection caused by uropathogenic Escherichia coli. Clin. Microbiol. Infect. 12, 1034–1036. doi: 10.1111/j.1469-0691.2006.01543.x
Stacy, D. M., Welsh, M. A., Rather, P. N., and Blackwell, H. E. (2012). Attenuation of quorum sensing in the pathogen Acinetobacter baumannii using non-native N-Acyl homoserine lactones. ACS Chem. Biol. 7, 1719–1728. doi: 10.1021/cb300351x
Starkey, M., Hickman, J. H., Ma, L., Zhang, N., De Long, S., Hinz, A., et al. (2009). Pseudomonas aeruginosa rugose small-colony variants have adaptations that likely promote persistence in the cystic fibrosis lung. J. Bacteriol. 191, 3492–3503. doi: 10.1128/JB.00119-09
Subashchandrabose, S., Smith, S. N., Spurbeck, R. R., Kole, M. M., and Mobley, H. L. (2013). Genome-wide detection of fitness genes in uropathogenic Escherichia coli during systemic infection. PLoS Pathog. 9:e1003788. doi: 10.1371/journal.ppat.1003788
Svensson, A., Larsson, L., Emtenas, H., Hedenstrôm, M., Fex, T., Hultgren, S. J., et al. (2001). Design and evaluation of pilicides: potential novel antibacterial Agents directed against uropathogenic Escherichia coli. Chembiochem 12, 915–918. doi: 10.1002/1439-7633(20011203)2:12<915::AID-CBIC915>3.0.CO;2-M
Tang, K., Su, Y., Brackman, G., Cui, F., Zhang, Y., Shi, X., et al. (2015). MomL, a novel marine-derived N-acyl homoserine lactonase from Muricauda olearia. Appl. Environ. Microbiol. 81, 774–782. doi: 10.1128/AEM.02805-14
Teiber, J. F., Horke, S., Haines, D. C., Chowdhary, P. K., Xiao, J., Kramer, G. L., et al. (2008). Dominant role of paraoxonases in inactivation of the Pseudomonas aeruginosa quorum-sensing signal N-(3-oxododecanoyl)-L-homoserine lactone. Infect. Immun. 76, 2512–2519. doi: 10.1128/IAI.01606-07
Tielker, D., Hacker, S., Loris, R., Strathmann, M., Wingender, J., Wilhelm, S., et al. (2005). Pseudomonas aeruginosa lectin LecB is located in the outer membrane and is involved in biofilm formation. Microbiology 151, 1313–1323. doi: 10.1099/mic.0.27701-0
Tomaras, A. P., Dorsey, C. W., Edelmann, R. E., and Actis, L. A. (2003). Attachment to and biofilm formation on abiotic surfaces by Acinetobacter baumannii: involvement of a novel chaperone-usher pili assembly system. Microbiology 149, 3473–3484. doi: 10.1099/mic.0.26541-0
Tomaras, A. P., Flagler, M. J., Dorsey, C. W., Gaddy, J. A., and Actis, L. A. (2008). Characterization of a two-component regulatory system from Acinetobacter baumannii that controls biofilm formation and cellular morphology. Microbiology 154, 3398–3409. doi: 10.1099/mic.0.2008/019471-0
Valentini, M., and Filloux, A. (2016). Biofilms and Cyclic di-GMP (c-di-GMP) Signaling: lessons from Pseudomonas aeruginosa and other bacteria. J. Biol. Chem. 291, 12547–12555. doi: 10.1074/jbc.R115.711507
Vallet, I., Olson, J. W., Lory, S., Lazdunski, A., and Filloux, A. (2001). The chaperone/usher pathways of Pseudomonas aeruginosa: identification of fimbrial gene clusters (cup) and their involvement in biofilm formation. Proc. Natl. Acad. Sci. U.S.A. 98, 6911–6916. doi: 10.1073/pnas.111551898
Vandeputte, O. M., Kiendrebeogo, M., Rajaonson, S., Diallo, B., Mol, A., El Jaziri, M., et al. (2010). Identification of catechin as one of the flavonoids from Combretum albiflorum bark extract that reduces the production of quorum-sensing-controlled virulence factors in Pseudomonas aeruginosa PAO1. Appl. Environ. Microbiol. 76, 243–253. doi: 10.1128/AEM.01059-09
Wang, J., Zhou, J., Donaldson, G. P., Nakayama, S., Yan, L., Lam, Y. F., et al. (2011). Conservative change to the phosphate moiety of cyclic diguanylic monophosphate remarkably affects its polymorphism and ability to bind DGC, PDE, and PilZ proteins. J. Am. Chem. Soc. 133, 9320–9330. doi: 10.1021/ja1112029
Wang, X., Preston, J. F. III., and Romeo, T. (2004). The pgaABCD locus of Escherichia coli promotes the synthesis of a polysaccharide adhesin required for biofilm formation. J. Bacteriol. 186, 2724–2734. doi: 10.1128/JB.186.9.2724-2734.2004
Weber, H., Pesavento, C., Possling, A., Tischendorf, G., and Hengge, R. (2006). Cyclic-di-GMP-mediated signalling within the sigma network of Escherichia coli. Mol. Microbiol. 62, 1014–1034. doi: 10.1111/j.1365-2958.2006.05440.x
Wexselblatt, E., Katzhendler, J., Saleem-Batcha, R., Hansen, G., Hilgenfeld, R., Glaser, G., et al. (2010). ppGpp analogues inhibit synthetase activity of Rel proteins from Gram-negative and Gram-positive bacteria. Bioorg. Med. Chem. 18, 4485–4497. doi: 10.1016/j.bmc.2010.04.064
Wong, D., Nielsen, T. B., Bonomo, R. A., Pantapalangkoor, P., Luna, B., and Spellberg, B. (2017). Clinical and pathophysiological overview of acinetobacter infections: a century of challenges. Clin. Microbiol. Rev. 30, 409–447. doi: 10.1128/CMR.00058-16
Wu, H., Song, Z., Hentzer, M., Andersen, J. B., Molin, S., Givskov, M., et al. (2004). Synthetic furanones inhibit quorum-sensing and enhance bacterial clearance in Pseudomonas aeruginosa lung infection in mice. J. Antimicrob. Chemother. 53, 1054–1061. doi: 10.1093/jac/dkh223
Yang, F., Wang, L. H., Wang, J., Dong, Y. H., Hu, J. Y., and Zhang, L. H. (2005). Quorum quenching enzyme activity is widely conserved in the sera of mammalian species. FEBS Lett. 579, 3713–3717. doi: 10.1016/j.febslet.2005.05.060
Zhang, Y., Brackman, G., and Coenye, T. (2017). Pitfalls associated with evaluating enzymatic quorum quenching activity: the case of MomL and its effect on Pseudomonas aeruginosa and Acinetobacter baumannii biofilms. PeerJ 5:e3251. doi: 10.7717/peerj.3251
Zheng, Y., Tsuji, G., Opoku-Temeng, C., and Sintim, H. O. (2016). Inhibition of P. aeruginosa c-di-GMP phosphodiesterase RocR and swarming motility by a benzoisothiazolinone derivative. Chem. Sci. 7, 6238–6244. doi: 10.1039/C6SC02103D
Zhou, E., Seminara, A. B., Kim, S. K., Hall, C. L., Wang, Y., and Lee, V. T. (2017). Thiol-benzo-triazolo-quinazolinone Inhibits Alg44 Binding to c-di-GMP and reduces alginate production by Pseudomonas aeruginosa. ACS Chem. Biol. 12, 3076–3085. doi: 10.1021/acschembio.7b00826
Zhou, J., Sayre, D. A., Wang, J., Pahadi, N., and Sintim, H. O. (2012). Endo-S-c-di-GMP analogues-polymorphism and binding studies with class I riboswitch. Molecules 17, 13376–13389. doi: 10.3390/molecules171113376
Zhou, J., Watt, S., Wang, J., Nakayama, S., Sayre, D. A., Lam, Y. F., et al. (2013). Potent suppression of c-di-GMP synthesis via I-site allosteric inhibition of diguanylate cyclases with 2'-F-c-di-GMP. Bioorg. Med. Chem. 21, 4396–4404. doi: 10.1016/j.bmc.2013.04.050
Keywords: Pseudomonas aeruginosa, Escherichia coli, Acinetobacter baumannii, c-di-GMP, pilicides and curlicides, quorum sensing, anti-biofilm compounds
Citation: Qvortrup K, Hultqvist LD, Nilsson M, Jakobsen TH, Jansen CU, Uhd J, Andersen JB, Nielsen TE, Givskov M and Tolker-Nielsen T (2019) Small Molecule Anti-biofilm Agents Developed on the Basis of Mechanistic Understanding of Biofilm Formation. Front. Chem. 7:742. doi: 10.3389/fchem.2019.00742
Received: 23 August 2019; Accepted: 17 October 2019;
Published: 01 November 2019.
Edited by:Manuel Simões, University of Porto, Portugal
Copyright © 2019 Qvortrup, Hultqvist, Nilsson, Jakobsen, Jansen, Uhd, Andersen, Nielsen, Givskov and Tolker-Nielsen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Tim Tolker-Nielsen, firstname.lastname@example.org